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ABSTRACT 
 
Genome regulation is an extremely complex phenomenon. There are various 
mechanisms in place to ensure smooth performance of the organism. Post-
transcriptional regulation of gene expression is one such mechanism. Many 
proteins bind to mRNAs and regulate their translation. In this thesis, I have 
focused on the Cytoplasmic Polyadenylation Element Binding family of proteins 
(CPEB1-4); a group of sequence specific RNA binding proteins important for cell 
cycle progression, senescence, neuronal function and plasticity. CPEB protein 
binds mRNAs containing a short Cytoplasmic Polyadenylation Element (CPE) in 
3’ untranslated Region (UTR) and regulates the polyadenylation of these mRNAs 
and thereby controls translation. In Chapter II, I have presented my work on the 
regulation of mitochondrial function by CPEB. CPEB knockout mice have brain 
specific defects in mitochondrial function owing to a reduction in Electron 
transport chain complex I component protein NDUFV2. CPEB controls the 
translation of this NDUFV2 mRNA and thus affects mitochondrial function. A 
consequence of this reduced bioenergetics is reduced growth and branching of 
neurons, again emphasizing the importance of this pathway. Chapter III focuses 
on the role of CPEB4 in neuronal survival and protection against apoptosis. 
CPEB4 shuttles between nucleus and cytoplasm and becomes nuclear in 
response to stimulation with ionotropic glutamate receptors, focal ischemia in 
 vii 
 
vivo and when cultured neurons are deprived of oxygen and glucose; nuclear 
CPEB4 affords protection against apoptosis in ischemia model. The underlying 
cause for nuclear translocation is reduction in Endoplasmic Reticulum calcium 
levels. These studies give an insight into the function and dynamics of these two 
RNA binding proteins and provide a better understanding of cellular biology. 
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 CHAPTER I 
 
INTRODUCTION 
 
Translation 
DNA is the blueprint of almost all life forms. Its information is interpreted 
through its conversion into RNA molecules.  Of special importance is a molecule 
in the RNA category –mRNA. DNA is transcribed into mRNA and the mRNA is 
co-transcriptionally modified by addition of a 7-methylguanosine cap at the 5’ 
end, a poly (A) tail at the 3’ end, removal of introns by splicing and deposition of 
RNA binding proteins on some mRNAs leading to formation of large mRNP 
complexes. This decorated mRNA is then exported from the nucleus and is ready 
to be translated into protein, which are the workhorses of the cell as they perform 
most of the functions in living systems. The process of mRNA translation occurs 
in the distinct steps of initiation, elongation and termination. Initiation occurs 
when the pre-initiation complex (containing ribosomal small 40S subunit, Met-
tRNA, initiation factors such as eIF4E, eIF4G, eIF4A) binds to the cap structure 
on 5’ end of mRNA and scans the mRNA to locate the AUG start codon. The 
large 60S ribosomal subunit then joins and elongation ensues (Sonenberg and 
Hinnebusch, 2009). The Ribosome has three sites important for peptide bond 
1
 formation- A (aminoacyl), P (peptidyl) and E (exit) sites. The process of 
elongation is much simpler. tRNAs charged with amino acids (also called 
aminoacyl-tRNAs) are delivered to the ribosomal A site by the elongation factor 
eEF1A. Only if the anticodon on the tRNA corresponds to the codon on the 
mRNA it is retained on the A site, the rest of the incorrect tRNAs are expelled 
from the ribosome. A peptide bond is then formed between the amino acid on the 
A site and the amino acid on the P site of the ribosome. The elongation factor 
eEF2 promotes translocation of the ribosome along mRNA and each codon is 
thus read and translated into amino acid by the ribosome. Termination of 
translation is mediated by the release factor eRF1, which recognizes one of the 
three stop codons (UAG, UAA, UGA) and binds to ribosome leading to GTP 
hydrolysis by eRF3 and release of the nascent polypeptide from the ribosome. 
This poises the ribosome for recycling to prepare it for another round of 
translation. The ribosome is a large ~3.3 megadalton ribonucleoprotein complex 
with a sedimentation coefficient of 80S and as detailed before is the site of all 
protein synthesis in the cell (Schmeing and Ramakrishnan, 2009).  
Initiation of translation is the first step and is therefore also the rate-limiting 
step. Initiation requires at least nine initiation factors comprised of more than 30 
polypeptide chains, thus introducing many opportunities for regulation (reviewed 
in (Groppo and Richter, 2009). Various mechanisms of initiation control have 
been described over the years. Some of them control general translation of all 
mRNAs (as happens in stress or starvation conditions) whereas others are more 
2
 sequence specific such as micro RNAs or RNA binding proteins. The most well 
characterized translation control factor is eIF4E-binding protein (4E-BP) family of 
proteins named after its founder member eIF4E-BP. These proteins bind eIF4E 
and prevent its binding to eIF4G, thereby shutting down cap-dependent 
translation. Phosphorylation of 4E-BPs disrupts their interactions with eIF4G and 
thus relieves the inhibition. PI3 kinase/Akt/mTOR and Ras/MAPK signaling 
pathways regulate the phophorylation of 4E-BP and affect translation thus 
controlling cell growth, metabolism, proliferation, development, learning and 
memory (Sonenberg and Hinnebusch, 2007) . Several other proteins such as 
maskin, neuroguidin and cup also act similar to 4E-BP but bind to mRNA in a 
sequence specific manner.  The translation initiation factor eIF2 is also under 
intense control especially during stress and starvation. eIF2B is the guanine 
nucleotide exchange factor which converts its substrate, inactive eIF2-GDP, into 
active eIF2-GTP, which can then bind the methionine charged initiator tRNA and 
participate in translation initiation. Under conditions of stress or starvation, the α 
subunit of eIF2 is phosphorylated thereby preventing eIF2B from binding and 
recycling this important initiation factor, bringing translation to a halt (Merrick, 
1992). 
Initiation is a highly regulated step in translation. The steps of elongation 
and termination are less regulated. Once the message in the coding sequence of 
the mRNA is initiated the ribosome elongates the message and termination 
occurs at the termination codon. Apart from the coding sequence, mRNAs also 
3
 possess untranslated (UTR) regions in their 5’ as well as 3’ ends. These UTR 
sequences provide many options for regulating the mRNAs. Many RNA binding 
proteins bind to mRNAs at these sites and control the expression of the mRNA. 
The 3’ UTR is a special focus of this thesis.        
Polyadenylation 
Virtually all mRNAs, with the exception of histone mRNAs, are decorated 
with a cotranscriptionally added long poly (A) tail at the 3’ UTR. This process 
occurs in the nucleus. The poly (A) tail has been suggested to be important for 
transcription termination, mRNA stability, translation efficiency and mRNA 
transport.  Most mRNAs contain a polyadenylation signal consisting of two 
elements- a hexanucleotide (hex) sequence AAUAAA which lies 10-30 bases 
upstream of the cleavage/polyadenylation site, the second signal is a GU rich 
sequence located 30-40 bases downstream of the cleavage site. 3’ end of the 
mRNA is processed by 2 steps- first is cleavage of the mRNA between these two 
signal sequences by an endonucleolytic process; second is the addition of poly 
(A) tail. The hex sequence is recognized by the cleavage and polyadenylation 
specificity factor (CPSF). It has been known for some time that cleavage occurs 
by formation of a 3’ end processing complex on the mRNA; this complex is 
composed of the four proteins CPSF, cleavage stimulation factor (CstF), 
cleavage factors I and II (Colgan and Manley, 1997; Zhao et al., 1999). Recently 
Shi et al dissected the molecular architecture of the 3’ end processing complex 
4
 by performing large scale proteomic analysis (Shi et al., 2009). The 3’ end 
processing complex is more composite than previously imagined and is 
composed of more than 80 proteins. Cleavage is accompanied by 
polyadenylation of the mRNA and the two processes occur simultaneously in 
vivo. Poly (A) polymerase (PAP) is the enzyme that adds the multiple adenosine 
(A) nucleotides to the 3’ end of mRNA. The maximum number of residues in the 
poly (A) tail is limited to 200-300; this is maintained by the poly (A) binding 
protein (PABP), which has a high affinity to poly (A) tracts. PABP also supports 
translation initiation by binding to the initiation factor eIF4G and thus circularizing 
the mRNA by bringing the 5’ and 3’ ends of the mRNA in close proximity.   
There is evidence of regulation of the mRNA at the polyadenylation stage. 
Many mRNAs possess multiple polyadenylation signals and alternate 
polyadenylation can lead to differential mRNA subsets of the same pre-mRNA 
and affect the protein length and other processing functions. 
Cytoplasmic polyadenylation 
Upon undergoing polyadenylation in the nucleus, mRNAs are exported out 
of the nucleus into the cytoplasm. In some cases, the polyadenylation status of 
the mRNAs alters in the cytoplasm as detailed below. This phenomenon of 
cytoplasmic polyadenylation was discovered in Xenopus oocytes and is used as 
a means of translation control by regulating the length of poly(A) tail. Cytoplasmic 
polyadenylation process is mediated by CPEB (Cytoplasmic Polyadenylation 
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 Element Binding Protein), an RNA binding protein that associates with the U-rich 
(UUUUUAU) cytoplasmic polyadenylation element (CPE) in the 3’UTRs of 
responding mRNAs. By doing so, it regulates the polyadenylation-induced 
translation of target mRNAs through formation of a large RNA-protein complex 
that includes cleavage and polyadenylation specificity factor (CPSF), the non-
canonical poly(A) polymerase germline development factor 2 (Gld2), the 
deadenylase poly (A) ribonuclease (PARN), Neuroguidin (Ngd), the scaffold 
protein symplekin, and other factors (Richter, 2007). CPEB was originally 
discovered in Xenopus during studies on the development of Xenopus oocytes 
which occurs through various stages. The full grown oocytes remain in their 
immature state until they receive the development cue of induction by steroid 
hormone progesterone whereupon the oocytes mature into fertilizable eggs. 
Molecularly, progesterone stimulation activates Mos/MEK/MAP kinase pathway, 
which leads to release of the oocytes from cell cycle arrest. These arrested 
oocytes contain many mRNAs in dormant/masked state, which undergo 
stimulation dependent translation. Several of these masked/dormant mRNAs 
have short poly(A) tails which get elongated upon stimulation leading to their 
polyadenylation-mediated translation. All the mRNAs are tagged with a long 
poly(A) tail when they emerge from the nucleus, but mRNAs containing CPE 
elements in their 3’UTR attract CPEB and its associated factors gld-2 and PARN 
(Mendez and Richter, 2001). Gld-2 is the poly(A) polymerase that adds 
adenosine moieties to the mRNAs and PARN is the deadenylase which removes 
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 the adenosine moieties. Because PARN is a faster acting enzyme, the net effect 
is shortening of the poly(A) tail and entrance of the mRNA into a dormant state 
(Kim and Richter, 2006).  Upon CPEB’s phosphorylation at Ser174 by Aurora 
kinase, the deadenylase is dissociated from the mRNA-protein complex which 
facilitates the elongation of poly(A) tail. Phosphorylation of CPEB also promotes 
the recruitment of poly(A) binding protein (PABP) which stabilizes the poly(A) and 
further facilitates translation of the mRNA. One important mRNA whose 
translation is regulated using this mechanism is cyclin B1, a protein essential for 
cell cycle regulation (Groisman et al., 2000) (Figure 1.1). 
In some mRNAs an additional regulation by the protein maskin also 
occurs. Maskin is a CPEB binding protein which also binds eIF4E at the site 
where eIF4G normally binds, thus creating competition between eIF4G and 
maskin for eIF4E binding. eIF4E is the cap binding translation initiation factor and 
eIF4G is the translation initiation factor required for recruitment of 40S ribosomal 
subunit to the 5’ UTR of the mRNA. CPE-containing mRNAs are maintained in 
translational dormant state due to maskin binding and its sequestration of eIF4E, 
making it non-available for eIF4G binding and thus repressing translation. When 
poly(A) tail is elongated, poly(A) binding protein (PABP) binds to the poly(A) tail 
and recruits eIF4G which helps it to displace maskin from eIF4E. Thus, 
translation ensues (Stebbins-Boaz et al., 1999).   
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 Figure 1.1 Translation control by CPEB in neurons 
CPEB binds to CPE elements in the 3’UTR of mRNA and recruits several factors 
Gld2, PARN, Ngd on the scaffolding factor Symplekin resulting in shorter poly (A) 
tail of the mRNA and translation inhibition. Stimulation of the neuron leads to 
Aurora A catalyzed phosphorylation of CPEB and concomitant changes in the 
CPEB complex leading to expulsion of PARN and resumption of polyadenylation 
and translation of the mRNA (details in text). 
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Figure 1.1 
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 CPEB-mediated translation is required for several biological phenomena. 
CPEB is important for oocyte and sperm development as shown by studies in 
CPEB knockout mice; female CPEB KO mice have no detectable ovaries and the 
testis is 30% smaller in CPEB KO male mice (Tay and Richter, 2001).  During 
meiosis in oocytes, CPEB plays a role in formation of synaptonemal complex 
through regulation of the mRNAs for synaptonemal complex proteins 1 (SCP1) 
and 3 (SCP3). In addition to its role in meiosis, CPEB also plays a role in 
regulating mitotic cell cycle progression (Novoa et al., 2010). CPEB has also 
been shown to shuttle between nucleus and cytoplasm; nuclear CPEB is 
important for regulating pre-mRNA splicing of a collagen 9a1 mRNA (Lin et al., 
2010). CPEB also plays a role in regulating localization of ZO-1 mRNA and 
thereby regulating cellular tight junctions (Nagaoka et al., 2012). CPEB 
modulates hepatic insulin resistance by regulating translation of Phosphatase 
and Tensin homolog (PTEN) and Signal Transducer and Activator of 
Transcription 3 (STAT3) (Alexandrov et al.). Synaptic plasticity and learning and 
memory is also regulated by CPEB; neuronal CaMKII has CPE elements and is 
regulated by CPEB-mediated translational activation (Alarcon et al., 2004; 
Berger-Sweeney et al., 2006). CPEB regulates cell growth and senescence in 
human as well as mouse fibroblasts. Fibroblasts derived from CPEB knockout 
(KO) mice bypass senescence as do human skin fibroblasts depleted of CPEB 
(Burns and Richter, 2008; Groisman et al., 2006); in both cell types, reduced p53 
mRNA translation is a key event causing the immortalization (Burns and Richter, 
10
 2008; Groppo and Richter).  CPEB depletion, at least in human fibroblasts, 
results in the Warburg Effect, a cancer-related phenomenon in which ATP 
production by mitochondrial oxidative phosphorylation is impaired but 
compensated for by increased glycolysis (Burns and Richter, 2008; Levine and 
Puzio-Kuter; Vander Heiden et al., 2009).  
CPEB in neurons 
CPEB is highly abundant in the brain, kidney, lung and ovary (Theis et al., 
2003; Wu et al., 1998). In the brain, CPEB is localized to the post-synaptic 
density (PSD) fraction of the synapse. Synapses are the structures where one 
neuron communicates with another and the PSD fraction is the electron dense 
region immediately below the postsynaptic membrane where a variety of 
signaling molecules are present. The PSD fraction also contains various 
translational machinery components suggesting that many mRNAs may undergo 
local translation in this compartment. Activation of the synapse by the 
neurotransmitter glutamate via activation of N-methyl D-aspartate (NMDA) 
receptors causes phosphorylation of CPEB at Thr 171 which activates CPEB and 
thus facilitates polyadenylation and translation of CPE-containing mRNAs 
(Huang et al., 2002). The polyadenylation-mediated activation by CPEB in 
neurons occurs in the same manner as in the Xenopus oocyte; activation of 
CPEB leads to expulsion of PARN and elongation of the poly(A) tail  by Gld-2 
(Udagawa et al., 2012). It has been shown that CPEB plays a role in 
11
 polyadenylation and thus local translation of calcium/calmodulin dependent 
protein kinase II (αCaMKII) mRNA at the synapse (Huang et al., 2002). αCaMKII 
plays a very important role in synaptic transmission and plasticity. CPEB 
knockout (KO) mice (Tay and Richter, 2001) show defects in hippocampus 
dependent memory, specifically in the form of memory known as extinction 
(Berger-Sweeney et al., 2006). Extinction is the process where conditioned 
responses diminish and gradually become extinct over time as the animal learns 
to uncouple a response from a stimulus. Improper extinction leads to impaired 
learning of new tasks. Synaptic plasticity is the ability of neurons to change their 
strength upon activation by a stimulus. Certain forms of synaptic plasticity known 
as long term potentiation (LTP) and long term depression (LTD) are affected in 
CPEB KO mice. CPEB KO mice show defects in LTP evoked by theta burst 
stimulation (Alarcon et al., 2004) and growth hormone stimulation (Zearfoss et 
al., 2008). In Drosophila, Orb2 is the homolog of CPEB and its reduction causes 
impairment specifically in long-term memory but not in short-term memory 
(Keleman et al., 2007). Aplysia CPEB has been shown to form amyloidogenic 
oligomers when over expressed and these oligomers increase in an activity-
dependent manner in neurons (Si et al., 2003a; Si et al., 2003b). Drosophila 
Orb2 has also been shown to form such oligomers upon neuronal stimulation and 
Drosophila mutants defective in forming these oligomers have impaired long-term 
memory (Majumdar et al., 2012). CPEB also controls mRNA transport in neurons 
(Huang et al., 2003). CPEB binds CPE containing mRNAs and transports them to 
12
 dendrites from the cell body (soma). It is likely that these CPE containing mRNAs 
then get translationally activated upon synaptic stimulation. CPEB also has been 
shown to be important for experience-dependent dendritic morphogenesis in 
Xenopus optical tectal neurons (Bestman and Cline, 2008, 2009). Taken 
together, these studies reveal the importance of CPEB in neuronal activity, 
neuronal mRNA transport and memory consolidation.  
CPEB family proteins  
Invertebrates such as Drosophila have 2 CPEB-like proteins (Orb1 and 
Orb2), but vertebrates have four CPEB like proteins, namely CPEB, CPEB2, 
CPEB3 and CPEB4 (Theis et al., 2003). Drosophila melanogaster Orb1 is similar 
to CPEB while Drosophila melanogaster Orb2 has higher similarity to CPEB 2-4 
(Mendez and Richter, 2001). CPEB (also sometimes called CPEB1), is the 
founding member of the family. It was originally discovered in Xenopus laevis, 
but has now been shown to be present in many organisms including Homo 
sapiens (human), Rattus norvegicus (rat), Mus musculus (mouse), Pan 
troglodytes (chimpanzee), Macaca mulatta (rhesus monkey) and Bos taurus 
(cow). CPEB2 was originally discovered in mouse round spermatids, whereas 
CPEB3 and 4 were described in mouse brain and other tissues. It is now known 
that in mouse, CPEB2 is present in brain and testis. CPEB3 is present in brain 
and heart with weaker expression in liver, lung, kidney, embryo and ovary 
(Kurihara et al., 2003; Theis et al., 2003). CPEB4 mRNA expression is highest in 
13
 brain followed by heart, kidney, embryo, lung with weaker expression in liver, 
spleen and ovary.     
There is high conservation in the RNA-binding domains of these various 
CPEB family members (45% homology) but CPEB2, 3 and 4 have higher 
homology to each other than to CPEB (98 to 99% homology). The full length 
proteins have lesser conservation compared to the RNA-binding domains; CPEB 
2-4 show higher conservation with each other than to CPEB1 (Figure 1.2). 
CPEB3 and 4 bind to a U rich stem loop structure that is distinct from CPE 
(Huang et al., 2006). In transfected neurons, CPEB3 represses translation of 
reporter RNAs containing the stem loop structure; an endogenous mRNA target 
of CPEB3 is GluR2 whose translation is upregulated upon RNAi knockdown of 
CPEB3. The mechanism of action of CPEB3 is likely distinct from CPEB 
mediated translation regulation because CPEB3 neither binds AAUAAA nor 
interacts with cleavage and polyadenylation specificity factor (CPSF) (Huang et 
al., 2006). CPEB2-4 can be co- regulated by miRNAs 92 and 26 and the miRNA 
binding sites are located in the paralog positions suggesting conservation of this 
regulation throughout evolution (Morgan et al., 2010).  
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 Figure 1.2 CPEB family proteins 
Mouse CPEB family proteins (mCPEB1-4) have an N-terminal regulatory domain 
and a C terminal RNA binding domain containing the RNA Recognition Motifs 
(RRM) and Zinc Fingers (ZnF). Homology percentages of the full length CPEB1-
4 proteins (in black) and the RNA binding domains (in red) are also shown.  
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Figure 1.2 
 
 
 CPEB1 CPEB2 CPEB3  CPEB4 
CPEB1  23.8 24.8 24.6 
CPEB2 44.9  69.9 67.7 
CPEB3 44.9 99  56.8 
CPEB4 44.9 98.5 97.5  
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 CPEB2 has been shown to bind to hypoxia inducible factor 1 alpha  (HIF1 
α) mRNA and influence its expression by slowing down polypeptide elongation; 
CPEB2 also binds to eEF2 and inhibits eEF2/ribosome triggered GTP hydrolysis, 
thus slowing down translation elongation of CPEB2 bound mRNAs (Chen and 
Huang, 2012; Hagele et al., 2009). 
 CPEB3 and 4 mRNA levels are elevated in hippocampus following 
kainite-induced seizures, suggesting their importance in synaptic activity (Theis 
et al., 2003).  Drosophila Orb2, which has high homology to CPEB2-4 has a role 
in long term male courtship memory (Keleman et al., 2007). CPEB3 has a highly 
conserved self cleaving human delta virus (HDV) like ribozyme in one of its 
introns; a single nucleotide polymorphism in this ribozyme affects its cleaving 
properties and is associated with human episodic memory (Salehi-Ashtiani et al., 
2006). In mouse, CPEB3 has been shown to affect synaptic plasticity by 
influencing the translation of GluA1 and GluA2 subunits of AMPA receptors and 
growth of new dendritic spines. The ubiquitin ligase neuralized monoubiquitinates 
CPEB3 and increases its activity, which in turn leads to increased AMPA 
receptors (Pavlopoulos et al., 2011). Apart from its role in translation, CPEB3 
also partners with signal transducer-activated transcription (Stat) 5b and acts as 
a transcriptional inhibitor of the tyrosine kinase epidermal growth factor receptor 
(EGFR) upon shuttling to the nucleus. EGFR is known to regulate LTP, learning 
and memory (Peng et al., 2010).   
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 CPEB4 mRNA possesses CPEs in its 3’UTR and is regulated by CPEB 
generating a positive loop to sustain cytoplasmic polyadenylation throughout the 
various stages of meiosis (Igea and Mendez, 2010). Even during mitosis, CPEB 
4 and CPEB1 coordinately regulate polyadenylation of hundreds of mRNAs to 
achieve successful entry into M phase and promote cell proliferation (Novoa et 
al., 2010). Recently it has been revealed that CPEB4 has some pro-oncogenic 
properties. It is upregulated in pancreatic ductal adenocarcinomas and 
glioblastomas and knockdown of CPEB4 reduces tumor growth, vascularization 
and invasion. Translational control of tissue plasminogen activator (tPA) is one of 
the major causes for the tumor progression (Ortiz-Zapater et al., 2012). 
  CPEB family proteins have been shown to influence various aspects of 
cell physiology suggesting that these proteins play a crucial role.   
Mitochondrial physiology 
Mitochondria are the energy producing organelles of the body and also are 
required for calcium homeostasis, apoptosis, and amino acid and lipid 
metabolism. They are double membrane organelles enclosing a matrix in the 
centre and an intermembrane space in between the two membranes. The inner 
membrane is folded into cristae and houses the components of the Electron 
transport chain (ETC). The ETC is a series of protein complexes (I-V) through 
which electrons flow and protons are pumped out to the intermembrane space 
and thus, generate a proton gradient across the inner membrane. ATP synthase 
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 transports protons from the intermembrane space to the matrix down their 
gradient and uses this energy to couple a phosphate group to ADP to generate 
ATP (Figure 1.3). 
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 Figure 1.3 Schematic of mitochondrial structure and function. 
The mitochondrion is a double membrane structure with an Outer and Inner 
membrane enclosing a matrix. Electron transport chain complexes I-IV transport 
electrons and generate a proton gradient across the inner membrane which is 
utilized by the complex V to produce ATP. Transport of newly synthesized 
proteins into mitochondria occurs through the TOM and TIM complexes; upon 
entry into mitochondria the mitochondrial targeting sequence is cleaved. 
Mitochondrial DNA (mtDNA) and the TCA cycle are also shown. Role of 
mitochondria in calcium buffering and Reactive Oxygen species (H2O2, O2-) is 
also shown. 
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Figure 1.3 
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 Different tissues possess varying amounts of mitochondria. Some tissue 
specificity arises due to different requirements and functions of the particular 
tissue. For instance, only liver tissue performs urea synthesis. One of the 
enzymes involved in this process ornithine transcarbomylase is present only in 
liver mitochondria. Other tissue specific metabolic pathways involving 
mitochondria are gluconeogenesis and ketone body production in liver, steroid 
hormone production in adrenal cortex, deamination of glutamine in kidney, 
utilization of lactic acid by sperm, uncoupling and generation of heat by brown 
adipose tissue (reviewed in (Johnson et al., 2007; Kunz, 2003). Tissue specificity 
also arises due to different subunit composition of the electron transport chain 
complexes. Cytochrome c oxidase (also called Complex IV) components display 
the most diverse tissue specific expression of isoforms. The enzyme is 
composed of 13 subunits, of which isoforms are known for 4 of the subunits 
namely IV, VIa, VIIa and VIII. The γ subunit of ATP synthase also has two 
isoforms- H type in muscle and heart and L type in brain, liver and kidney (Kunz, 
2003). These two isoforms are produced as a result of alternate splicing. The 
differential composition of mitochondria is probably a consequence of different 
requirements of tissues. Brain for instance is a high energy requiring organelle 
and thus possesses higher amounts of mitochondria. As a consequence of 
different composition of mitochondria different tissues have variable sensitivities 
to defects in mitochondria (Kuznetsov et al., 2009).     
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  The mitochondrial proteome is made up of approximately 1100 proteins 
(Pagliarini et al., 2008). Of these, 13 are encoded by the mitochondrial genome. 
Mitochondrial DNA in vertebrates is a covalently closed molecule of 16.5 
kilobases. It encodes 13 protein components of Complexes I, III, IV and V, 22 
tRNAs and 2 rRNAs (reviewed in (Chen and Butow, 2005). The remainder of the 
mitochondrial proteome is encoded by nuclear DNA. These nuclear encoded 
mitochondrial proteins possess a mitochondria targeting signal (MTS) in the 
amino terminal or internally in the protein, which is recognized by the 
translocation complex of outer mitochondrial membrane (TOM) and then by the 
translocation complex of inner mitochondrial membrane (TIM) (Chacinska et al., 
2009). The nuclear encoded mitochondrial proteins are very tightly regulated. 
They are transcriptionally regulated by various transcription factors such as 
PGC1 alpha, EEG-1 etc (Hock and Kralli, 2009; Scarpulla, 2008). 
Mitochondrial dysfunction can prove disastrous for the cell and 
consequentially to the organism. Many human diseases such as schizophrenia, 
bipolar disease, dementia, Alzheimer's disease, epilepsy, migraine headaches, 
strokes, neuropathic pain, Parkinson's disease, ataxia, transient ischemic attack, 
cardiomyopathy, coronary artery disease, chronic fatigue syndrome, 
fibromyalgia, retinitis pigmentosa, diabetes, hepatitis C, and primary biliary 
cirrhosis are caused or exacerbated by mitochondrial dysfunction (Pieczenik and 
Neustadt, 2007). Apart from disease, the normal progression of aging also has 
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 mitochondrial links. ROS produced by mitochondria has been shown to lead to 
faster aging (Van Remmen and Richardson, 2001).  
Electron Transport Chain Complex I 
Mitochondrial electron transport chain complex I, also known as NADH 
dehydrogenase, whose function is to couple oxidation of NADH to the reduction 
of ubiquinone, is the first and largest complex in ETC. Homo sapiens (Human) 
and Bos tauras (bovine) CI is made up of about 45 subunits, 14 of which are part 
of the core complex. Electron microscopy studies have revealed that mammalian 
CI assumes an L shaped conformation consisting of a peripheral matrix 
protruding arm and mitochondrial inner membrane (MIM) imbedded membrane 
arm. The assembly of complex I is very intricate and involves at least 7 identified 
assembly factors and proceeds through formation of 6 identified intermediate 
complexes. It is an important source of reactive oxygen species (ROS) 
(Distelmaier et al., 2009; Koopman et al., 2010; Lazarou et al., 2009).   
Mitochondrial Fusion and fission 
Mitochondria form a dynamic network; their shape ranges from cell-wide 
extended tubular networks to single isolated tubules. Such dynamic structure is a 
result of various fission and fusion events occurring throughout the neurons. In 
vertebrates, the GTPases mitofusins (Mfn1 and Mfn2) of the outer mitochondria 
and OPA1 in the intermembrane space are important for fusion. Another dynamin 
related protein (Drp1) which is present in cytoplasm along with the mitochondria 
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 outer membrane protein Fis1 is involved in fission (Chan, 2006). Aberrant 
mitochondrial fusion and fission events are associated with many disorders. Mfn1 
and 2 are important for embryonic development, protection against cerebellar 
neurodegeneration and are the cause for Charcot Marie tooth disease as well as 
optic atrophy I (Delettre et al., 2000; Zuchner et al., 2004). Mitochondrial fission 
has been observed to be important for apoptosis and neuronal function in 
mammalian culture (Ishihara et al., 2009). 
Mitochondria in brain 
The brain is highly dependent on mitochondrial oxidative phosphorylation 
for its energy requirements. In fact, the brain constitutes only 2% of body weight, 
but consumes 20% of total body oxygen and 25% of glucose (Raichle and 
Gusnard, 2002). Maintenance of ion gradients, synaptic potentials, action 
potentials and uptake and recycling of neurotransmitters are some of the major 
energy consuming processes of brain. Even when neuronal firing decreases to 
the minimum and electroencephalogram (EEG) becomes silent showing 
negligent neuronal activity, oxidative ATP production only halves, suggesting that 
half of the ATP expenditure in the brain is utilized in housekeeping functions 
(Mironov, 2009). It is hypothesized that most mitochondria are synthesized in the 
cell body of neurons and dysfunctional mitochondria also are transported back to 
cell bodies. They are transported over great distances in the various long 
processes of neurons; this transport occurs via microtubules which are attached 
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 to the mitochondria through motor adaptor proteins (Sheng and Cai, 2012). More 
than half of all mitochondria in brain are in dendrites and cell body (soma), 30% 
are in axons and rest in the glia (Mironov, 2009) . Synapses are particularly rich 
in mitochondria.  In fact, in earliest electron microscopy explorations, synapses 
were indeed located based on their high density of mitochondria (Hollenbeck, 
2005).  
Brain activity dependent mitochondrial dynamics 
Mitochondrial distribution and dynamics are adaptable to the cell 
physiological status. Mitochondria are found in increased numbers in presynaptic 
terminals and also in postsynaptic dendritic spines during synaptic activity (Kann 
and Kovacs, 2007). In fixed preparations, mitochondrial position can be 
correlated to the previous neuronal activity, with increased numbers of 
mitochondria found in areas of increased activity (Mironov, 2009). Mitochondria 
are transported to activated zones through two signals - one is the ATP levels 
and the other is the calcium concentration (Sheng and Cai, 2012). During 
development, mitochondria have been shown to move toward active growth 
cones in developing neurons (Morris and Hollenbeck, 1993). 
Mitochondria and synaptic plasticity 
Dendritic mitochondria have been shown to be important for the plasticity 
of dendritic spines. In Drosophila, Milton protein is important for mitochondrial 
distribution to nerve terminals. Mutant flies lacking Milton have defective synaptic 
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 transmission, suggesting the importance of pre-synaptic mitochondria in synaptic 
function (Stowers et al., 2002). In mammalian neurons, it was shown that 
mitochondria are dynamically distributed to dendritic regions in response to 
synaptic stimulation (Li et al., 2004). Rat hippocampal neurons mutant for the 
mitochondrial fission proteins Drp1 and Opa1 have defective synaptic 
transmission (Li et al., 2004).  Synaptic activity leads to changes in calcium 
currents in the neuron and mitochondria are important for calcium buffering, thus 
emphasizing the importance of mitochondria in synaptic plasticity. The 
mitochondrial permeability transition pore is a complex consisting of the voltage 
dependent anion channel (VDAC) in the outer membrane, adenine nucleotide 
transporter in the inner membrane and cyclophilin D in the matrix and is found in 
all mitochondria. This complex was shown to be important for synaptic plasticity 
and learning in mice (Weeber et al., 2002).     
  
Mitochondrial function is regulated by various mechanisms as described 
above. CPEB-deficient human fibroblasts also have reduced mitochondrial mass 
and function (Burns and Richter, 2008). Because CPEB controls both energy 
production in human fibroblasts and synapse function in the brain (Alarcon et al., 
2004; Zearfoss et al., 2008), we surmised that there might be a link between the 
two, and that there might be reduced mitochondrial activity in neurons that lack 
CPEB. In light of these observations, I studied the role of CPEB in mitochondrial 
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 function in mouse. I specifically focused on brain tissue because neurons have 
higher energy demand and are rich in mitochondria.  
CPEB family proteins also play important roles in neuronal function as 
detailed earlier. In this thesis, I have explored the role of CPEB4 in neuronal 
survival and its dynamics in response to neuronal stimulation, ischemia and 
calcium concentration changes.   
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 Abstract 
 
Mitochondrial energy production is a tightly regulated process involving 
the coordinated transcription of several genes, catalysis of a plethora of 
posttranslational modifications, and the formation of very large molecular 
supercomplexes.  The regulation of mitochondrial activity is particularly important 
for the brain, which is a high energy-consuming organ that depends on oxidative 
phosphorylation to generate ATP.  Here we show that brain mitochondrial ATP 
production is controlled by the cytoplasmic polyadenylation-induced translation of 
an mRNA encoding NDUFV2, a key mitochondrial protein.  Knockout mice 
lacking the Cytoplasmic Polyadenylation Element Binding protein  (CPEB) have 
brain-specific dysfunctional mitochondria and reduced ATP levels, which is due 
to defective polyadenylation-induced translation of electron transport chain 
complex-I protein NDUFV2 mRNA.  This reduced ATP results in defective 
dendrite morphogenesis of hippocampal neurons both in vitro and in vivo.  These 
and other results demonstrate that CPEB control of mitochondrial activity is 
essential for normal brain development. 
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 Introduction 
 
Mitochondrial ATP production accounts for ~90% of the energy produced 
in mammalian cells and thus the regulation of mitochondrial function is critically 
important for cell growth and viability.  Nuclear-encoded mitochondrial proteins 
are regulated transcriptionally by various factors such as Nuclear Respiratory 
factors NRF1 and NRF2, stimulatory protein 1 (Sp1), estrogen related receptor α 
(ERRα), and yin yang 1 transcription factor (YY1) (Scarpulla, 2008).  PGC1α 
plays a role in coordinating the expression of mitochondrial subunits 
commensurate with changes in the environment (Lin et al., 2005).  Mitochondrial 
activity is also regulated by the formation of supercomplexes that allow for 
substrate channeling (Shoubridge, 2012).  Post-translational modifications affect 
mitochondrial function (Koc and Koc, 2012), as does tissue-specific expression of 
different mitochondrial proteins that generate unique mitochondrial dynamics to 
accommodate different requirements for a given tissue (Pagliarini et al., 2008). 
 The Cytoplasmic Polyadenylation Element Binding Proteins (CPEBs) are 
a family of four RNA binding proteins that are widely expressed in vertebrates 
(reviewed in (Mendez and Richter, 2001).  CPEB1 is the founding member of this 
family; it associates with the cytoplasmic polyadenylation element (CPE), a U-
rich (UUUUUAU) structure generally residing within 100 bases of the AAUAAA 
pre-mRNA cleavage and polyadenylation signal in the 3’ UTRs of specific 
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 mRNAs.  CPEB proteins 2-4 probably also associate with U-rich structures 
(Novoa et al., 2010), but they do not appear to recognize the CPE with the same 
high affinity as CPEB1 (Huang et al., 2006).  Although all CPEB proteins regulate 
mRNA expression (Chen and Huang, 2012; Huang et al., 2006; Novoa et al., 
2010; Wang and Huang, 2012), CPEB is centrally important for promoting 
translation by stimulating cytoplasmic polyadenylation.  CPEB is the key 
component of the cytoplasmic polyadenylation complex, which also includes 
cleavage and polyadenylation specificity factor (CPSF), the non-canonical 
poly(A) polymerase Gld2, the deadenylating enzyme PARN, the scaffold protein 
symplekin, poly(A) binding protein (PABP), and Maskin or Neuroguidin (Ngd), 
which also bind the cap-binding factor eIF4E (Barnard et al., 2004; Kim and 
Richter, 2006, 2007; Richter, 2007; Udagawa et al., 2012).  When associated 
with these factors in a large ribonucleoprotein (RNP) complex, CPE-containing 
mRNAs have short poly(A) tails and are translationally repressed.  In response to 
an environmental cue, the kinase Aurora A phosphorylates CPEB, which causes 
the dissociation of PARN from the RNP complex resulting in default Gld2-
catalyzed polyadenylation (Kim and Richter, 2006; Mendez et al., 2000).  The 
newly elongated poly(A) tail then is bound by PABP, which also binds the 
initiation factor eIF4G.  eIF4G subsequently displaces Maskin from eIF4E and 
thereby recruits other initiation factors and the 40S ribosomal subunit to the 5’ 
end of the mRNA (Cao et al., 2006; Kim and Richter, 2007). 
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 CPEB-mediated translation is required for several biological phenomena 
including oocyte development (Tay and Richter, 2001), neuronal synaptic 
plasticity and learning and memory (Alarcon et al., 2004; Berger-Sweeney et al., 
2006; Udagawa et al., 2012; Zearfoss et al., 2008), cell growth (Burns and 
Richter, 2008; Groisman et al., 2006), and hepatic insulin resistance (Alexandrov 
et al.).  Fibroblasts derived from CPEB knockout (KO) mice bypass senescence 
as do human skin fibroblasts depleted of CPEB (Burns and Richter, 2008; 
Groisman et al., 2006); in both cell types, reduced p53 mRNA translation is a key 
event causing the immortalization (Burns and Richter, 2008; Groppo and 
Richter).  CPEB-depletion, at least in human fibroblasts, results in the Warburg 
Effect, a cancer-related phenomenon in which ATP production by mitochondrial 
oxidative phosphorylation is impaired but compensated for by increased 
glycolysis (Burns and Richter, 2008; Levine and Puzio-Kuter, 2010; Vander 
Heiden et al., 2009).  The reduced p53 levels in CPEB-depleted cells lowers 
synthesis of cytochrome c oxidase (SCO2), which in turn impairs electron 
transport chain complex IV activity. 
In this study, we sought to investigate whether CPEB deficiency results in 
impaired mitochondrial function in animal tissue.  Surprisingly, we observed that 
in CPEB knockout (KO) animals, mitochondrial energy production was reduced in 
the brain and neurons but not muscle or liver and was unaccompanied by 
elevated glycolysis as occurs in the Warburg Effect.  Further analysis showed 
that the polyadenylation of electron transport chain complex I protein NDUFV2 
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 mRNA was compromised in neurons, which caused reduced levels of the protein 
and hence inefficient oxygen consumption and ATP production.  As a 
consequence of depressed ATP levels, dendrite morphogenesis was also 
reduced in CPEB-deficient hippocampal neurons both in vitro and in vivo.  
Impaired dendrite branching and growth in CPEB-deficient neurons was rescued 
when normal levels of ATP were restored.  These and other observations reveal 
an essential and unexpected role for translational control in energy production in 
the brain. 
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 Results 
 
CPEB deficiency leads to reduced mitochondrial function 
To assess whether CPEB KO mice have altered bioenergetics similar to 
CPEB-depleted fibroblasts, ATP levels were measured in extracts from brain, 
liver, and muscle.  Although the latter two tissues had no change in ATP 
concentration compared to wild type (WT), the brain displayed a ~56% reduction 
while cultured hippocampal neurons derived from CPEB KO mice showed a 32% 
reduction (Figure 2.1A).  We measured the recovery of ATP from brain lysates by 
titrating in known amounts of this nucleoside triphosphate.  Using our extraction 
procedure, there was a 41% recovery of ATP from WT and a 50% recovery from 
CPEB KO brain lysates; consequently, the values shown in the figure reflect 
corrected values for the recovery of ATP.  The reduced ATP in CPEB KO brain 
may be contrasted to the effect observed in human foreskin fibroblasts in which 
CPEB depletion, while reducing mitochondrial ATP production, had no effect on 
overall ATP levels because of a compensatory up-regulation of glycolysis.  This 
phenomenon of reduced mitochondrial ATP production and elevated glycolysis is 
known as the Warburg Effect and is a characteristic of cancer cells that may 
contribute to malignant transformation (Dang, 2012; Vander Heiden et al., 2009).  
In the brain, normal levels of ATP were restored in the CPEB1 KO neurons when 
they were infected with lentivirus expressing CPEB-HA (Figure 2.1B), indicating 
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 that the depletion of ATP is reversible.  Next, we determined whether shRNA-
depletion of CPEB in WT neurons had a similar effect on ATP generation.  As 
shown in Figure 2.2A , a ~65% depletion of CPEB was accompanied by a ~65% 
reduction in ATP only upon shRNA depletion of this protein but not when a 
control non-silencing (NS) shRNA was used (Figure 2.1B).  These results show 
that CPEB controls energy balance specifically in neurons.  
To investigate how CPEB regulates ATP levels, oxygen consumption was 
measured and shown to be reduced by ~50% in CPEB KO brain as well as 
cultured CPEB KO hippocampal (Figure 2.1C) and cortical neurons (Figure 
2.2B); oxygen consumption in CPEB KO glia, however, was unchanged (Figure 
2.2C).  Oxygen consumption in brain lysates and hippocampal neurons was also 
determined in the presence of mitochondrial inhibitors rotenone plus antimycin 
and shown to be completely inhibited, indicating that the oxygen consumption we 
measured was entirely mitochondrial (Figure 2.1C).  We also found that oxygen 
consumption in brain lysates increased for 54 min after which time it diminished.  
This non-linear measurement could be due to clumps of cells in the brain lysates 
that might have incomplete access to nutrients and oxygen, thus leading to the 
death of some of the neurons.  Lactate production, which indicates efficiency of 
glycolysis, was unaltered in CPEB KO brain or neurons (Figure 2.2D), 
demonstrating that the reduction in ATP was not compensated by enhanced 
glycolysis.  Mitochondrial levels as determined by mitochondrial DNA (Figure 
2.1D) and cytochrome C content (Figure 2.1E) were unchanged in neurons, 
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 indicating that an alteration in the mass of mitochondria was not responsible for 
reduced ATP production in CPEB-depleted neurons.  Mitochondrial morphology 
in WT and CPEB KO neurons as determined by confocal microscopic 
examination of mitotracker-stained cells showed no significant differences 
(Figure 2.2E), indicating that the gross morphology of mitochondria was 
unaffected by the loss of CPEB.  However, mitochondrial membrane potential as 
measured by the fluorescent dye tetramethylrhodamine methyl ester (TMRM) 
was reduced by 40-60% in DIV 2-20 cultured CPEB KO neurons (Figure 2.1F).  
Mitochondria have a negative resting membrane potential and TMRM is a 
cationic dye which preferentially accumulates in the mitochondria and to alesser 
extent in Endoplasmic reticulum. These data demonstrate that mitochondrial 
function, but not mitochondrial mass, is reduced in CPEB KO brain and neurons.  
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 Figure 2.1. CPEB controls mitochondrial ATP production. 
(A) ATP levels in brain, liver, muscle, and hippocampal neurons from 5 WT and 5 
CPEB KO mice.  (B) ATP in WT and CPEB KO hippocampal neurons isolated 
from 3 different embryos infected with lentiviruses expressing shRNA against 
CPEB (CPEB KD), non-silencing shRNA (NS), or HA-tagged CPEB  (CPEB).  (C) 
Oxygen consumption in 4 WT and 4 CPEB KO brain and cultured hippocampal 
neurons with or without the inhibitors (inhi) rotenone plus antimycin. (D) Quasi-
quantitative PCR of mitochondrial (mt) and tubulin DNAs in WT and CPEB KO 
brain.  (E) Western blots of the mitochondrial protein cytochrome C and actin in 
WT and CPEB KO brain.  (F) Mitochondrial membrane potential as measured by 
TMRM in 7 hippocampal neurons each from 8 WT and 8 CPEB KO embryos 
cultured for 2-20 days in vitro (DIV). (*p<0.05; **p<0.01 Student’s t test, all 
experiments were done in 3 replicates, the bars indicate SEM).  
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 Figure 2.2 Bioenergetics defect caused by CPEB deficiency is specific to 
neurons and is not compensated by glycolysis. 
(A) Western blot showing knock down of CPEB using shRNA against CPEB 
(CPEB KD). Tubulin served as a loading control. (B) Oxygen consumption in WT 
and CPEB KO cortical neurons. (C) Oxygen consumption in glia cultured from 
WT and CPEB KO mouse brains. (D) Lactate levels in WT and CPEB KO brain 
and cultured hippocampal neurons. (E) Mitochondrial morphology imaged using 
mitotracker green FM in WT and CPEB KO neurons. (The bars refer to SEM). 
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 Mitochondrial insufficiency is due to an impairment of electron transport 
chain complex I 
The electron transport chain consists of four multi-protein complexes that 
sequentially transfer electrons to generate a proton gradient across the inner 
mitochondrial membrane, which is utilized by ATP synthase to phosphorylate 
ADP to produce ATP (Figure 2.3A).  The actions of each of the complexes were 
measured in mitochondria isolated from WT and CPEB KO mouse brains.  
Because exogenous substrates were used for the assays, each complex was not 
influenced by the activity of any other.  The activities of complexes I and II 
showed a statistically significant decline in the CPEB KO mitochondria; complex I 
activity in particular was strongly reduced by ~60% (Figures 2.3B-E).  Citrate 
synthase, which indicates mitochondrial function unrelated to electron transport 
was similar in WT and CPEB KO brain (Figure 2.4A).  Complex I and II activities 
were also determined by measuring oxygen consumption of isolated respiring 
mitochondria using an oxygen electrode.  Oxygen consumption was measured in 
the presence of complex I substrates malate plus glutamate or succinate, a 
complex II substrate.  As shown in Figure 2.3F and Table 2.1, oxygen 
consumption in both WT and CPEB KO mitochondria increased significantly 
upon addition of mitochondria to the reaction mix.  The rate of oxygen 
consumption further increased upon addition of ADP (state 3 respiration).  
However, the rate of oxygen consumption was lower in CPEB KO mitochondria 
in the presence of complex I substrates but was unaffected in the presence of the 
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 complex II substrate, again demonstrating that CPEB KO mitochondria are 
defective for complex I activity. 
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 Figure 2.3 CPEB regulates the activity of electron transport chain complex I  
(A) Schematic of mitochondrial electron transport chain complexes I-V.  (B-E) 
Activities of electron transport chain (ETC) complexes I-IV in mitochondria from 3 
WT and 3 CPEB KO mouse brain. (F) Oxygen consumption of mitochondria 
isolated from WT or CPEB KO brains.  Mitochondria were incubated in a 
chamber containing an oxygen sensor; oxygen consumption was measured in 
the presence of complex I (malate plus glutamate) or complex II substrates 
(succinate).  ADP was added to stimulate state 3 respiration. (*p<0.05; **p<0.01 
Student’s t test, 3 replicates, the bars indicate SEM).  
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 Table 2.1 State 3 respiration rates in WT and CPEB KO mitochondria  
 WT 0.2 mM ADP CPEB KO 0.2 mM ADP 
Complex I, III, IV  
5 mM Glutamate+ 5  mM 
Malate  
229 ± 25* 
 
180 ± 43* 
 
Complex II, III, IV 
5 mM Succinate  
178 ± 46 168 ± 11 
 
 
Mitochondria isolated from WT and CPEB KO brains were analyzed for Complex 
I activity using glutamate and malate as substrates and for complex II using 
succinate as the substrate. Both measurements took place in presence of 0.2 
mM ADP. The values represent mean ± SEM from 3 replicates. *P value= 1.22 
(Not significant). 
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 Reactive oxygen species (ROS) were increased by ~ 60 and 80% in the 
CPEB KO brain  and neurons, respectively (Figure 2.4B).  Complex I is a 
significant generator of ROS in mitochondria, which could explain why CPEB KO 
mitochondria have increased ROS.  To determine whether the increased ROS 
leads to increased oxidative damage, the levels of protein carbonyl groups were 
measured as an indicator of oxidative damage.  Carbonyl groups are produced 
on amino side chains (especially of proline, arginine, lysine, threonine) when they 
are oxidized.  As shown in Figure 2.4C, CPEB KO brain had only very slightly 
elevated protein oxidative damage. 
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 Figure 2.4 Citrate synthase and ROS levels in WT and CPEB KO brain lysates 
and neurons 
(A) Citrate synthase activity measured in WT and CPEB KO brain mitochondria 
after normalizing to total protein.  (B) Reactive oxygen species (ROS) measured 
in WT and CPEB KO brain lysates and neurons. (C) Oxidative damage assessed 
by measuring amount of protein carbonyl groups in WT and CPEB KO brain 
lysates. (The bars refer to SEM). 
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 We next used blue native PAGE and western blotting to examine specific 
proteins in each intact complex isolated from WT and CPEB KO mitochondria.  
Because the blue native PAGE is non-denaturing, the electron transport chain 
complexes remain intact and are not dissociated into their constituent subunits.  
Figure 2.5A shows that in contrast to proteins in complexes II, III, IV, and V, 
complex I was reduced by ~40% (as shown by blotting for its proteins NDUFV2 
and NDUFA9) in the CPEB KO mitochondria.  Complex II was not affected in the 
blue native PAGE analysis but its activity was reduced by about 20% in CPEB 
KO mitochondria (Figure 2.3C), suggesting that the dysfunction in complex II is 
not due to the loss of its constituent proteins.  Examination of complex I proteins 
in total brain extracts demonstrates a reduction, by ~35%, only of NDUFV2 in the 
CPEB KO samples (Figure 2.5B).  NDUFV2 mRNA levels, however, were 
comparable in WT and CPEB KO brain, pehaps the untranslated mRNA gets 
turned over (Figure 2.5C).  These data suggest not only that reduced NDUFV2 in 
CPEB KO mitochondria is responsible for impaired ATP production, but that the 
levels of this protein might also be regulated at the posttranscriptional level. 
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 Figure 2.5 CPEB regulates the expression of complex I protein NDUFV2 
(A) Blue Native PAGE-resolved intact ETC complexes from mitochondria isolated 
from 3 WT and 3 CPEB KO brains and selected proteins in complexes I-V were 
analyzed by western blotting.  Quantification is shown on the histogram.  (B) 
Western blots were probed for mitochondrial proteins from total lysates from 3 
WT and 3 CPEB KO brains.  Quantification is shown on the histogram.  (C) 
Quantitative RT-PCR analysis of NDUFV2, NDUFS4, and tubulin mRNAs in 3 
WT and 3 CPEB KO brains.  (*p<0.05; **p<0.01 Student’s t test, 3 replicates, the 
bars indicate SEM).  
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 Complex I protein NDUFV2 expression is reduced in CPEB KO mice 
NDUFV2 is one of 14 core catalytic subunits of complex I; it is synthesized 
in the cytoplasm and imported into mitochondria via an amino terminal 
mitochondrial targeting sequence (MTS) (Figure 2.6A).  To test whether reduced 
NDUFV2 in CPEB KO mitochondria is responsible for impaired ATP production, 
CPEB KO neurons were infected with lentiviruses expressing NDUFV2 or as 
controls, NDUFV2 that lacks either its MTS or NDUFS4.  Figure 2.6B shows that 
ATP levels were restored to nearly WT levels by ectopic MTS-containing, but not 
MTS-lacking NDUFV2.  ATP levels were unaffected by ectopic expression of 
NDUFS4 (a complex I constituent whose levels were unchanged in CPEB KO) 
suggesting that the effect on ATP in CPEB KO neurons is specifically due to 
reduced NDUFV2 (Figure 2.6B).  Complex I activity in CPEB KO neurons was 
also restored to nearly wild-type levels by ectopic expression of NDUFV2 (Figure 
2.6C). These results demonstrate that reduced NDUFV2 in CPEB KO neurons 
leads to deficient mitochondrial ATP production.  
NDUFV2 mRNA contains 3’ UTR CPEs, which although downstream of 
the AAUAAA, could still support cytoplasmic polyadenylation (Fox et al., 1989).  
Based on this observation, we thought this mRNA might be directly regulated by 
CPEB.  To assess this possibility, WT neurons were infected with a lentivirus 
expressing CPEB-HA, followed by HA immunoprecipitation and RT-PCR analysis 
for co-precipitating RNAs.  As shown in Figure 2.6D, NDUFV2 mRNA was 
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 immunoprecipitated with CPEB-HA but not when the cells were not transduced 
with CPEB-HA (mock IP).  GAPDH and NDUFS4 mRNAs were not co-
precipitated with CPEB-HA, indicating its specificity for NDUFV2. 
The decrease in amount of NDUFV2 in CPEB KO brains (Figure 2.5B) 
could be due to decreased translation or increased degradation.  To determine 
whether the synthesis of NDUFV2 is altered in CPEB KO neurons, cells were 
pulse labeled with 35S-methionine for 1 hour followed by immunoprecipitation with 
NDUFV2 antibody.  Because of the short incubation time, the radiolabeled 
NDUFV2 reflects new synthesis but very little degradation because protein 
destruction usually occurs over several hours.  Figure 2.6E shows that NDUFV2 
was synthesized ~40% less efficiently in CPEB KO compared to WT neurons, 
suggesting that CPEB mediates the translation of NDUFV2 mRNA.  To 
investigate this possibility further, neurons were transfected with plasmids 
encoding firefly luciferase mRNA (transfection control) and Renilla luciferase 
mRNA appended with the NDUFV2 3’ UTR containing or lacking the CPEs (see 
Figure 2.6A).  When determined 3 days after transfection, the Renilla luciferase 
activity was 25% higher when the reporter RNA contained the 3’ UTR CPEs 
(Figure 2.6F).  These data indicate that the cytoplasmic polyadenylation 
elements promote the translation of NDUFV2 mRNA. 
Finally, an examination of NDUFV2 mRNA shows that the length of its 
poly(A) tail was reduced by ~ 30 nts in CPEB KO versus WT brain; the poly(A) 
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 tail of tubulin mRNA was similar in each genotype (Figure 2.6G).  Equal amounts 
of NDUFV2 and tubulin mRNAs from WT and CPEB KO were used for the assay.  
Taken together, the data in Figure 2.6 indicate that the control of ATP levels in 
neurons by CPEB is mediated by polyadenylation and translation of NDUFV2 
mRNA. 
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 Figure 2.6 CPEB regulates NDUFV2 mRNA translation 
(A) Schematic of NDUFV2 mRNA showing the mitochondrial targeting signal, 
polyadenylation hexanucleotide AAUAAA, and CPEs.  (B) ATP was measured in 
WT and CPEB KO hippocampal neurons infected with lentiviruses expressing 
NDUFV2, or a mutant NDUFV2 lacking the MTS or NDUFS4. (C) Complex I 
activity was measured in WT and CPEB KO hippocampal neurons infected with 
lentivirus expressing NDUFV2. (D) WT hippocampal neurons were infected with 
lentivirus expressing HA-CPEB.  HA antibody was used to co-immunoprecipitate 
CPEB followed by RT-PCR for NDUFV2, NDUFS4, and GAPDH mRNAs.  (E) 
WT and CPEB KO hippocampal neurons were incubated with 35S-methionine 
followed by immunoprecipitation of NDUFV2 and analysis by SDS-PAGE.  WCE 
refers to whole cell extract.  The histogram shows the quantification of 
immunoprecipitation.  (F) The coding region of Renilla luciferase was appended 
with the WT NDUFV2 3’ UTR or one that lacked the CPEs (3’UTR mut) (see 
panel A).  Plasmids encoding these constructs as well as firefly luciferase to 
serve as a control were transfected into neurons and analyzed for luciferase 
activity 3 days later.  The data are plotted as the ratio of Renilla luciferase activity 
to firefly luciferase activity.  (G) A PCR-based polyadenylation assay was used to 
determine the poly(A) tails of NDUFV2 and tubulin mRNAs in WT and CPEB KO 
brain (primers a/dT anchor).  The internal primers (a/b) indicate the relative 
amount of RNA in each sample. (*p<0.05; **p<0.01 Student’s t test, 3 replicates, 
the bars indicate SEM). 
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 Dendritic branching is impaired in CPEB KO mice  
We surmised that reduced brain ATP in CPEB KO mice might impair 
neuron growth and/or morphogenesis.  To assess this possibility, neurons from 
WT and CPEB KO mice were immunostained for tubulin and subjected to a Sholl 
analysis where concentric rings surrounding a neuron with the cell body in the 
center are used to measure dendrite branching.  Although neurons from both 
genotypes appeared similar during the initial days of culture, by day 5 (Figure 
2.7A) the CPEB KO neurons showed 16% fewer dendrite branches (Figure 
2.7B); dendrite length was also reduced by ~19% (Figure 2.7C).  This result is 
similar to that observed by Bestman and Cline (Bestman and Cline, 2008), who 
examined the role of CPEB in dendrite morphogenesis using Xenopus laevis 
optic tectal neurons.  Dendrite branching was restored when CPEB was 
ectopically expressed in the DIV5 CPEB KO neurons following lentivirus infection 
(Figures 2.8A-B).  Moreover, reduced branching was observed in DIV5 WT 
neurons following shRNA-mediated CPEB depletion (Figure 2.8A-B).  These data 
demonstrate that CPEB controls dendrite morphology.  
To investigate whether reduced ATP production is causative for 
diminished dendrite arborization, CPEB KO neurons were cultured in medium 
containing phosphocreatine for 4 days in vitro, which increased ATP levels to 
nearly WT levels (Figure 2.7D) and dendrite branching to near WT levels 
(Figures 2.7E, F).  Treatment of WT neurons with phosphocreatine, which 
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 donates a high-energy phosphate to ADP to produce ATP, enhanced dendrite 
branching (Figures 2.7E, F).  These results indicate that inhibited dendrite 
development in CPEB KO neurons is most likely due to impaired ATP 
generation. 
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 Figure. 2.7 CPEB and ATP promote dendritic development. 
(A) Morphology of WT and CPEB KO hippocampal neurons immunostained for 
tubulin at different days of culture. Scale bar= 50 µm. (B) Sholl analysis was 
performed on WT and CPEB KO neurons cultured for 5 days (n= 60 neurons 
from 3 mice). (C) Dendrite length was determined for cultured WT and CPEB KO 
neurons (n= 50 dendrites of 14 neurons from 3 mice).  (D) WT and CPEB KO 
neurons were continuously supplemented with phosphocreatine followed by 
determination of ATP at DIV6.  (E) Morphology of DIV6 WT and CPEB KO 
neurons following treatment with phosphocreatine; they were immunostained for 
tubulin (scale bar= 50 µm). (F) Sholl analysis was performed on WT and CPEB 
KO neurons cultured in phosphocreatine (n=55 neurons from 3 mice) (* p<0.05, 
** p<0.01 Student’s t test, 3 replicates; the bars indicate SEM).  
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 Figure 2.8. CPEB knockdown and ectopic expression control dendrite branching 
(A)WT and CPEB KO hippocampal neurons were treated with lentiviruses 
expressing shRNA against CPEB (CPEB KD) or HA-tagged CPEB (mCPEB) and 
dendrite branching was imaged by immunostaining for tubulin.  Scale bar= 50 
µm. (B) Neurons treated as above were subjected to Sholl analysis. (The bars 
refer to SEM). 
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 To examine whether CPEB regulates dendrite extension in vivo, 
retroviruses expressing GFP and a scrambled or CPEB-directed shRNA were 
injected into the dentate gyrus (DG) of 6- to7- week- old mice (Ge et al., 2006).  
Two weeks post-injection, the dividing DG neurons were analyzed by serial 
sectioning and 3 dimensional reconstruction of confocal images of GFP-
immunostained cells.  Total dendrite length and branching were reduced by more 
than 50% in the knockdown (KD) compared to WT neurons (Figure 2.9A-C).  
CPEB depletion also reduced dendritic branching complexity of the neurons 
(Figure 2.9D).  Injection of a second shRNA against CPEB resulted in similar 
deficits in dendrite length and branching (not shown). Taken together, these data 
demonstrate that CPEB mediates neuronal maturation in vitro and in vivo.  
To assess whether ectopic expression of NDUFV2 in neurons rescues the 
reduction in dendrite morphology by CPEB depletion in vivo, retroviruses 
expressing CPEB shRNA and NDUFV2 containing or lacking its mitochondrial 
targeting sequence (MTS) were injected into the DG as was performed 
previously followed by serial sectioning and 3D reconstruction of GFP-stained 
images.  Figures 2.9 E and F show that dendrite branch number as well as 
dendritic length were increased upon expression of NDUFV2 containing but not 
lacking its MTS (mitochondrial targeting sequence).  The dendrite branching 
defect was also rescued by ectopic expression of NDUFV2, but not NDUFS4 in 
CPEB KO neurons in culture (Figure 2.9G), thus reaffirming the importance of 
NDUFV2 and mitochondrial energy production in dendrite branching.   
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 Figure 2.9 CPEB and NDUFV2 control dendrite morphology in vivo.  
(A) Three-dimensional (3D) confocal image reconstruction of dendrites from 
hippocampal dentate gyrus (DG) neurons that were stereotactically injected with 
retroviruses expressing GFP (control) or GFP and CPEB shRNA (14 dpi) (scale 
bar= 20 µm).  (B,C) Quantification of total dendritic length and branch number of 
dividing DG neurons. (D) Sholl analysis of dendrite complexity of dividing DG 
neurons (14 dpi) (n=4-6 animals) (* p<0.05, Student’s t test, 3 replicates;  ## 
p<0.01, 3 replicates); the bars indicate SEM). (E,F), Quantification of dendritic 
branch length and number following stereotactic DG injection of retroviruses 
expressing GFP and shRNA for CPEB plus either WT NDUFV2 or NDUFV2 that 
lacks its mitochondrial targeting sequence (MTS).  (n=12 animals) (G)  Sholl 
analysis of tubulin immunostained WT, CPEB KO and CPEB KO hippocampal 
neurons infected in vitro with lentiviruses expressing NDUFV2 or as control 
NDUFS4. (the bars indicate SEM). 
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 Figure 2.10 shows a model that summarizes the data described above.  In 
wild-type neurons, CPEB is associated with the 3’ UTR CPEs of NDUFV2 
mRNA.  At steady state or perhaps in response to an environmental cue, CPEB 
promotes poly(A) tail growth and translation of the mRNA, resulting in NDUFV2 
protein import into the inner mitochondrial membrane where it  is incorporated 
into complex I, thereby increasing flow of electrons through the electron transport 
chain and finally ATP is generated.  When neurons are CPEB deficient, reduced 
NDUFV2 mRNA translation and ATP production lead to neurite stunting and 
perhaps loss of synaptic connections and inhibited synapse efficacy (Alarcon et 
al., 2004; Zearfoss et al., 2008).  
 
 
 
 
 
 
 
 
 
68
 Figure 2.10 Model for CPEB control of energy production in neurons.  
CPEB associates with the 3’UTR CPEs of NDUFV2 mRNA in the cytoplasm of 
neurons.  This interaction promotes poly(A) tail growth and translation of 
NDUFV2 mRNA resulting in mitochondrial import of NDUFV2 protein, its 
incorporation into complex I, and elevated ATP production.  ATP in turn is 
necessary for promoting neurite morphogenesis.  In CPEB knockout (KO) 
neurons, a short poly(A) tail of NDUFV2 mRNA results in inefficient translation, 
which impedes complex I assembly and the generation of ATP.  As a 
consequence, neurite outgrown is curtailed.   
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 Discussion 
 
Our studies show that in CPEB KO brain and neurons, deficient 
polyadenylation-induced translation of the complex I component NDUFV2 mRNA 
impairs mitochondrial ATP production, thus demonstrating a role for translational 
control in mouse neuronal bioenergetics.  Why CPEB deficiency should inhibit 
ATP production only in the brain is unclear, but neurons as well as germ cells 
contain the greatest abundance of this protein, and thus NDUFV2 mRNA may 
not be regulated in other tissues because of a relative paucity of CPEB.  
Complex I levels also differ among tissues, which have different energy 
requirements and sensitivities to defects in oxidative phosphorylation 
(Distelmaier et al., 2009; Koopman et al., 2010; Kunz, 2003).  Perhaps the brain, 
which is the largest consumer of energy, may require CPEB to stimulate ATP 
generation in response to stress or synapse stimulation (Kann and Kovacs, 2007; 
Nicholls and Budd, 2000).  It is important to note that steady state levels of ATP 
are the result of both generation and consumption by cells.   Although our report 
demonstrates that CPEB controls ATP production by enhancing the translation of 
complex I protein NDUFV2 mRNA, we cannot rule out a possible effect of CPEB 
on ATP consumption as well.  The control of  ATP production by CPEB reported 
here contrasts to that which occurs during the Warburg Effect.  In transformed 
cells, aerobic glycolysis is due in part to aberrant splicing of pyruvate kinase; a 
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 predominant embryonic isoform, PKM2, is produced instead of the adult PKM1 
form (Christofk et al., 2008; David et al., 2010).  As a consequence, conversion 
of phosphoenolpyruvate (PEP) to pyruvate is reduced, limiting the amount of 
substrate for the tricarboxylic acid cycle (TCA) but stimulating the amount 
available for glycolysis (Chen et al., 2010). 
Experiments using Xenopus oocytes demonstrated that Aurora A-
catalyzed CPEB phosphoryation is necessary to stimulate very robust 
polyadenylation and translation (Barnard et al., 2004; Groisman et al., 2002; Kim 
and Richter, 2006; Mendez et al., 2000).  In neurons, CPEB phosphorylation is 
also important for polyadenylation in response to synaptic activity (Udagawa et 
al., 2012).  In these cases, CPEB responds to external signaling cues 
(hormones, synaptic stimulation) to promote the expression of generally 
quiescent or at least inefficiently translated mRNAs.  This CPEB-mediated on-off 
switch for translation may not function in quite the same way for the 
polyadenylation of NDUFV2 mRNA observed here.  That is, NDUFV2 would 
always be synthesized at some basal rate, but its expression might be turned up 
at times when ATP generation is particularly important such as when neurites 
respond to guidance cues as they navigate to their final destinations.  Thus, 
CPEB may act more like a rheostat to turn translation up or down rather than a 
switch to turn translation on or off.  The rheostat analogy may be similar to the 
case in MEFs or primary human fibroblasts where CPEB controls the expression 
of p53 in a relatively modest manner, although even a 50% change in p53 mRNA 
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 translation results in large alterations in cell physiology such as senescence 
bypass (Burns and Richter, 2008; Groisman et al., 2006; Groppo and Richter). 
The importance of CPEB phosphorylation for neurite outgrowth was 
suggested by experiments of Bestman and Cline (Bestman and Cline, 2008, 
2009), who electroporated a phosphorylation-defective “dominant negative” 
CPEB into Xenopus tadpole optic tectal neurons and observed reduced dendrite 
branching as well as glutamatergic synaptic strength.  These authors also 
showed that antisense morpholinos directed to CPEB mRNA, which would inhibit 
its translation, produced a similar effect.  In this same vein, Lin et al (Lin et al., 
2009) demonstrated that a “dominant negative” CPEB introduced into Xenopus 
retinal ganglion neurons inhibited axon growth cones from properly extending 
axons.  Although neither study identified the mRNA substrate(s) whose 
presumed reduced translation was responsible for the morphological defects in 
the neurons transduced with the dominant negative CPEB, our observations 
suggest that reduced ATP production caused by impaired NDUFV2 mRNA 
translation could be involved. 
Because CPEB is transported to dendrites (Huang et al., 2003) where it 
mediates polyadenylation (Udagawa et al., 2012), we surmise that NDUFV2 
mRNA polyadenylation and translation also occurs in dendrites and probably cell 
bodies as well.  Mitochondria are present at the base of dendritic spines where 
their ATP production is important for synapse function (Li et al., 2004).  We 
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 envision that dendritic ATP is also important for neurite outgrowth and 
morphogenesis and that when neurons are CPEB-deficient, reduced NDUFV2 
mRNA translation and ATP production lead to neurite stunting and perhaps loss 
of synaptic connections and inhibited synapse efficacy (Alarcon et al., 2004; 
Zearfoss et al., 2008).  Moreover, synapse stimulation not only induces CPEB-
dependent polyadenylation (Udagawa et al., 2012), but alterations in 
mitochondrial transport and localization as well (Chen and Chan, 2006).  Thus, 
the CPEB-mediated increase in mitochondrial activity could be an additional layer 
of stimulation-dependent regulation of ATP production. 
 Mitochondrial dysfunction is linked to several neurologic diseases 
including Parkinson’s, Alzheimer’s, and Huntington’s diseases as well as 
amyotrophic lateral sclerosis (Lin and Beal, 2006).  Aberrant complex I in 
particular may be causative for Leigh disease, a neurodegenerative disorder 
(Loeffen et al., 1998), and a number of encephalopathies such as seizures, 
brainstem lesions, and dystonia (Distelmaier et al., 2009).  These observations 
suggest that CPEB KO mice might also show signs of neurodegeneration elicited 
by impaired complex I activity.  Gross examination of the CPEB KO mice shows 
no obvious signs of this malady, however, neurodegenerative diseases are 
progressive and may become obvious only in older mice.  Consequently, further 
investigations are required to determine whether there is a neurodegenerative 
consequence to CPEB deficiency.  In any case, CPEB KO mice display reduced 
complex I activity by only ~50%, which might be insufficient to cause obvious 
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 phenotypes such as those noted above.  On the other hand, CPEB depletion 
reduces dendrite branching and development in the brain and alters synaptic 
efficacy.  Moreover, impaired mitochondrial function inhibits dendrite spine 
density and synaptic plasticity (Li et al., 2004), suggesting that in the case of 
CPEB KO mouse, defective complex I could be responsible, at least in part, for a 
deficit in hippocampal long-term potentiation and hippocampus-dependent 
learning and memory which could be tested by generating a transgenic CPEB 
KO mouse which over-expresses NDUFV2 and testing the LTP, learning and 
memory phenotypes (Alarcon et al., 2004; Berger-Sweeney et al., 2006).  
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 Materials and Methods 
 
Animals, neuron culture, and isolation of mitochondria 
 WT and CPEB C57BL/6 KO mice (Tay and Richter, 2001) were 
maintained in accordance with Institutional Animal Care and Use Committee 
(IACUC) of the University of Massachusetts Medical School.   
 The culture of primary hippocampal and cortical neurons was performed 
as described (Huang and Richter, 2007) in Neurobasal media (Invitrogen) 
containing B27 supplement (B27 media) and glutamine (1 µg/ml).  Liver, muscle, 
and brain were dissected from 1 month old female mice, washed and 
homogenized in Krebs-Ringers bicarbonate buffer (125 mM NaCl, 1.4 mM KCl, 
20 mM HEPES, pH 7.4, 5 mM NaHCO3, 1.2 mM MgSO4, 1.2 mM KH2,PO4, 1 mM 
CaCl2) containing 1% BSA.  Protein concentrations were determined using the 
BCA assay (Pierce).  Mitochondria were isolated using a MITO-ISO1 kit (Sigma) 
and following the manufacturer’s instructions. 
ATP determination 
Fifty to 100 µg of brain lysate was used to measure ATP concentration using the 
CellTiter-Glo Luminescent Cell Viability kit (Promega) in a 96 well format.  To 
measure ATP concentration in neurons, 60,000 cells were trypsinized from the 
dish, washed, and resuspended in 100 µl Krebs-Ringers bicarbonate buffer plus 
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 HEPES.  The brain lysates and the cultured neuron lysates were aliquoted into 
96 well plates and assayed according to manufacturer’s instructions.  To 
measure the recovery of ATP from brain lysates, known amounts of ATP (0.1, 1, 
10, and 100 µM) were used to measure ATP bioluminescene using the CellTiter-
Glo method as above in presence or absence of WT or CPEB KO brain lysate.  
The recovery of ATP was calculated from these values.  
Oxygen consumption 
To measure oxygen consumption in brain lysates, WT and CPEB KO mouse 
brains were washed and homogenized in 1 ml Krebs-Ringers bicarbonate buffer 
plus HEPES (125 mM NaCl, 1.4 mM KCl, 20 mM HEPES, pH 7.4, 5 mM 
NaHCO3, 1.2 mM MgSO4, 1.2 mM KH2,PO4, 1 mM CaCl2) containing 1% BSA.  
Fifty to 100 µg of protein from each lysate was aliquoted into a BD Oxygen 
biosensor systems plate (BD Biosciences) in triplicate and assayed on a SAFIRE 
multimode microplate spectrophotometer at 1 min intervals for 120 min at an 
excitation wavelength of 485 nm and emission wavelength of 630 nm. To 
measure oxygen consumption in neurons and glia, 80,000 cells were washed, 
suspended in 200 µl Krebs-Ringers bicarbonate buffer, and aliquoted onto a BD 
Oxygen Biosensor systems plate in triplicate and assayed as described above.  
To measure non-mitochondrial oxygen consumption, the brain lysates and 
neurons were treated with 1 µM rotenone plus 10 µM antimycin. 
Lentivirus production 
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 Lentiviruses expressing CPEB, NDUFV2, NDUFV2 Δmts or NDUFS4 were 
constructed by inserting mCPEB-HA, NDUFV2-HA, NDUFV2 Δmts-HA or 
NDUFS4  into the BamHI and XhoI sites of pFugw vector (Addgene).  For virus 
production, 10 µg of virus transfer vector that expressed the various constructs, 5 
µg gag-pol expressing vector, psPAX2 (from Addgene), and 5 µg VSV-G 
expressing vector, pMD2.G (from Addgene) were co-transfected into 1X107 293T 
cells plated in 10 cm culture dishes using the calcium chloride method.  Twenty-
four hours after transfection, the medium was replaced with Neurobasal medium 
containing B27 supplement (B27 media).  Forty-eight hours after transfection, the 
medium containing lentivirus was collected and passed through a 0.45 µm filter. 
To deplete CPEB, a pll 3.7 vector harboring shRNA against CPEB or a non-
silencing control was used to generate the lentivirus as described above.  
Mitochondrial DNA measurement 
Total genomic DNA was isolated from WT and CPEB KO brains using a Gentra 
Puregene Tissue kit (Qiagen).  Mitochondrial DNA was PCR amplified using the 
primers 5’ ACCATTTGCAGACGCCATAA 3’ and 
5’TGAAATTGTTTGGGCTACGG3’ to amplify the region between 2891 and 3173. 
PCR amplification was carried out in a 20 µl volume containing 10 µl Gotaq 
Green master mix (Promega), 1 µM each primer, and 20 ng of DNA. The PCR 
cycling conditions were: initial denaturation 94 °C for 3 mins, then 18 cycles of 
denaturation at 94 for °C for 1 min 30 secs, annealing at 53 °C for 2 min and 
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 elongation at 72 °C for 2 min 30 secs followed by final denaturation at 72 °C for 
13 mins. 
TMRM staining 
Cultured hippocampal neurons from WT and CPEB KO mice grown on coverslips 
for various days in vitro (DIV) were treated with 200 nm TMRM for 30 mins after 
which time they were washed with PBS and imaged using a Nikon ECLIPSE 
E600 fluorescence microscope. The fluorescent signal was then quantified using 
ImageJ software. 
Lactate measurement 
The concentration of lactate in 40,000 neurons was measured as described 
(Chang et al., 1992). The NADH produced by conversion of lactate to pyruvate 
by lactate dehydrogenase was measured at 340 nm using a SAFIRE 
spectrophotometer. Fifty to 100 µg of brain lysate or 40,000 neurons were 
suspended in 250 μl PBS before addition of HCl to a final concentration of 0.03 
N. The cells were then suspended in 50μl of 400 mM 2-amino-2-methylpropanol 
(Sigma), pH 9.9. A 4 ml assay cocktail containing 1 ml 15mM β-nicotinamide 
adenine dinucleotide (Sigma), 1 ml 400mM glutamate, pH 9 in 10mM PBS, and 2 
ml 10mM PBS, pH6.5. A typical assay included 40μl assay cocktail, 100μl 
sample or lactate standards (to generate a standard curve). Using a Tecan plate 
reader, absorbance of 340nm light prior to incubation with enzymes was 
performed. Twenty microliters of enzyme cocktail (200 U/ml L-lactate 
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 dehydrogenase and 80 U/ml glutamic-pyruvic transaminase in 10mM phosphate 
buffer, pH 6.5) was then added and the mixture was incubated 20 min at room 
temperature; absorbance at 340nm was then measured. 
Mitochondrial morphology determination 
To label mitochondria, neurons grown on coverslips were incubated with 100 nM 
mitotracker green FM for 20 min. Images were obtained using Zeiss AxioVert 
Confocal with a PerkinElmer UltraView Spinning Disc. 
Electron transport chain enzyme activities 
Purified mitochondrial samples were freeze-thawed three times before use in 
enzyme analysis to enable access of the substrate to the inner mitochondrial 
membrane. Enzyme activities were determined by adding exogenous substrates 
of the respective complexes and measuring the rate of conversion to product in 
isolated mitochondria.  All analyses were performed on an Ultraspec 2000 
UV/visible spectrophotometer (Pharmacia Biotech) in triplicate. Specific enzyme 
activities were calculated by subtracting the background activities using inhibitors 
to the complexes. 
Complex I 
Complex I activity was determined by measuring the decrease in absorbance of 
NADH at 340 nm (Birch-Machin and Turnbull, 2001). The assay was performed 
in buffer containing 50 mM KH2PO4, pH 7.4, 2 mM KCN, 5 mM MgCl2, 2.5 mg/mL 
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 BSA, 2 µM antimycin, 100 µM decylubiquinone, and 0.3 mM K2NADH.The 
reaction was started by adding purified mitochondria (20 µg) and the absorbance 
was measured every 30 secs for 5 min. Specific activity was measured by 
calculating slope of the reaction in the presence or absence of 1 µM of the 
complex I inhibitor rotenone. 
Complex II 
Complex II activity was determined by measuring reduction of DCIP at 600 nm 
(Ellis et al., 2005). The assay was performed in buffer containing 25 mM 
potassium phosphate, pH 7.4, 20 mM succinate, 2 mM KCN, 50 µM 2,6-
Dichlorophenolindophenol (DCIP), 2 µg/mL rotenone, 2 µg/mL antimycin and 10 
µg purified mitochondria. The reaction was initiated by adding 56 µM 
decylubiquinone. Specific activities were measured by calculating the slope of 
the reaction in the presence or absence of 0.5 mM thenolytrifluoroacetone, a 
complex II inhibitor. 
Complex III 
Complex III activity was determined by measuring the reduction of cytochrome C 
at 550 nm. The assay was performed in buffer containing 25 mM potassium 
phosphate, pH 7.2, 5 mM succinate, 5 µM rotenone, 1 mM KCN, 50 µM 
cytochome C and 20 µg purified mitochondria. The absorbance was measured 
every 30 secs for 5 min and specific activity determined by calculating slope of 
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 the reaction in presence or absence of 10 µg/ml antimycin A, a complex III 
inhibitor. 
Complex IV 
Complex IV activity was determined by measuring oxidation of ferrocytochrome 
C at 550 nm. Five µg of purified mitochondria was used to perform the assay 
using a COX activity kit (Sigma) following the manufacturer’s instructions. The 
specific activity was determined by calculating slope of the reaction in the 
presence or absence of 2.2 mM KCN, a complex IV inhibitor. 
Citrate synthase  
Citrate synthase activity was measured using 100 µl purified mitochondria in a 
total of 1 ml reaction solution containing 0.1 mM DTNB (Sigma), 0.15 mM acetyl-
CoA (Roche), 0.5 mM oxaloacetate (Sigma), and 65 mM Tris pH 8.1 (USB). 
Oxaloacetate was added just prior to the measurement. The absorbance was 
measured at 412 nm every 20 sec for 3 mins using the Ultraspec 2000 UV/visible 
spectrophotometer. The slope was calculated using Microsoft EXCEL. The citrate 
synthase activities were normalized to the total protein content. 
Measurement of mitochondrial respiration 
Mitochondria were isolated from WT and CPEB KO mouse brain using 
differential centrifugation as described earlier. Oxygen consumption in the intact 
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 mitochondria was measured using Clark type oxygen-sensitive electrode (YSI 
Incorporated).  The assays were performed as described (Li and Graham, 2012).  
Blue Native PAGE electrophoresis 
Mitochondria isolated from WT and CPEB KO mouse brain were resolved by 
Blue Native (BN)-PAGE as described (Wittig et al., 2006) and immunoblotted for 
mitochondrial proteins. 100 µg mitochondria was solubilized in 10 µl solubilization 
buffer (50 mM sodium chloride, 100 mM Bis-tris, 2 mM 6-aminohexanoic acid, 1 
mM EDTA, pH 7) and permeabilized at room temperature for 10 min using 2 µl of 
20% sodium dodecylmaltoside. The permeabilized mitochondrial fraction was 
collected by centrifugation at 20,000 xg for 25 min at 4 °C; to the supernatant, 2 
µl of 50% glycerol and 1 µl of 5% Coomassie Blue G-250 dye was added and 
loaded on 4-15 % Blue Native Bis-tris gel (NuPAGE, Invitrogen). The cathode 
buffer was 50 mM Tricine, 15 mM Bis-tris, and 0.02 % Coomassie Blue G-250 
and the anode buffer was 50 mM Bis-tris, pH 7.  The gel was run at 4 °C with the 
current limited to 15 mA and voltage limited to 500 V. After the dye front had 
moved about one-third of the distance, the cathode buffer was removed and 
replaced with cathode buffer containing 0.002% Coomassie Blue. After 
completion of the run, the proteins were immunoblotted onto PVDF membrane 
using electroblotting buffer (50 mM Tricine, 7.5 mM Bis-tris, pH 7) at 4°C for 3 hr 
with voltage set to 30 V. The membrane was destained with methanol and 
immunoblotting was performed using antibodies against the ETC complex 
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 proteins NDUFV2 (Genetex 1:1000), NDUFS4 (Mitosciences 1:1000), NDUFA9 
(Mitosciences 1:1000), NDUFS3 (Mitosciences 1:1000), CII subunit 70 kDa Fp 
(Mitosciences 1:1000), CIII subunit core 2 (Mitosciences 1:1000), CIV subunit 1 
(Mitosciences 1:1000), and ATP synthase subunit alpha (Mitosciences 1:1000). 
Reactive oxygen species measurement 
 ROS levels in 50 to 100 µg of brain lysate or 160,000 hippocampal 
neurons were determined using 10 µm CM-H2DCFDA (5-(and-6)-chloromethyl-
2',7'-dichlorodihydrofluorescein diacetate, acetyl ester, (Invitrogen) in Krebs 
ringer bicarbonate buffer. CM-H2DCFDA was excited at 504 nm and the emission 
at 529 nm was recorded every 5 mins for 1 hr in a Tecan plate reader.   
Oxidative damage measurement 
 Proetin carbonyl content was measured in lysates prepared from WT and 
CPEB KO mice brains using the 2,4-dinitrophenylhydrazine (DNPH) method as 
described (Forster et al., 1996). Brain lysate was made in 5 mM phosphate buffer 
(pH 7.5) containing 0.1 % Triton X-100 and protease inhibitors. The homogenate 
was centrifuged at 700 g and 300 µl aliquots of the supernatant were treated with 
300 µl of 10 mM DNPH or with 2 M HCl as control. Samples were incubated at 
room temperature for 1 hr, precipitated with 10% TCA and centrifuged for 3 min 
at 16000g. The pellet was washed 3 times with Ethanol/ Ethyl acetate (1:1 
vol/vol) and redissolved in 1 ml 6 M guanidine. Difference in absorbance between 
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 DNPH treated and HCl treated samples was determined at 366 nm and the 
results expressed as nmol carbonyl groups/mg protein.   
RNA analysis 
Total RNA was extracted from WT and CPEB KO mouse brain (100 mg) using 1 
ml Trizol (Invitrogen) according to the manufacturer’s instructions. 
Co-immunoprecipitation and RT-PCR 
Immunoprecipitation of mRNA-protein complexes was carried out on DIV 6 
cortical neurons infected with pFugw-CPEB-HA as described (Peritz et al., 2006). 
Immunoprecipitation was carried out using anti-HA antibody (Covance). The 
following gene specific primers were used for the 18 cycle PCR reaction carried 
out in a 20 µl reaction volume. The primers used for PCR were: 
NDUFV2 forward primer- 5’ CGAAAGCCAGTTGGGAAGTA,  
NDUFV2 reverse primer- 5’ CATCGGTGCATTTACACAGG,  
NDUFS4 forward primer- 5’ AATGGCTACAGCTGCCGTTT,  
NDUFS4 reverse primer- 5’ AAGCTGTGTGTCCCGAGTCT,  
GAPDH forward primer- 5’ CCTCAACTACATGGTCTAC,  
GAPDH reverse primer- 5’ CCTTCCCACATGCCAAAGT 
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 Translational efficiency  
 DIV10 WT hippocampal neurons were co-transfected with 2 µg of pGL-3 
and 2 µg of pRLTK-NDUFV2 3’UTR WT or 2 µg pRLTK-NDUFV2 3’UTR mutant.  
The transfected neurons were analyzed for Renilla luciferase and firefly 
luciferase using the dual luciferase assay system (Promega).  The Renilla 
luciferase values were normalized to the firefly luciferase activity levels, which 
accounts for transfection efficiencies.   
Metabolic labeling 
DIV 6 cortical neurons were cultured in 100 mm plate for 30 min in methionine 
and cysteine free media (Invitrogen); 60 µCi 35S-methionine (ProMix, Amersham) 
was then added and the cells were cultured for 1 hr. The radioactive media was 
removed, the cells were washed with 2 ml ice-cold PBS and scraped off the plate 
and pelleted. The cells were suspended in 1 ml of 50 mM Tris-HCl, pH 8, 150 
mM sodium chloride, 1% NP-40, 0.5 % sodium deoxycholate, 0.1% SDS and 
protease inhibitors (Complete ULTRA tablets, Roche Applied Science) and 
incubated on ice for 30 min. The lysate was cleared by centrifugation at 16,000 g 
for 15 min at 4 °C. The supernatant was used for immunoprecipitation. To 40 µl 
slurry of protein A Sepharose beads, 5 µl NDUFV2 antibody (Genetex) was 
added and the mixture rotated for 1 hr. in a cold room. Lysates from WT and 
CPEB KO cells containing equivalent counts of radioactivity were then added to 
the antibody-protein A bead mixture, which was rotated overnight at 4 °C. The 
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 beads were washed 3 times with ice cold wash buffer (50 mM Tris, pH 7.4, 300 
mM sodium chloride, 5 mM EDTA, 0.1 % triton-100) and resuspended in 100 µl 
SDS gel loading buffer for analysis by electrophoresis and phosphorimaging. 
PAT assay 
For analysis of the poly(A) tail of the NDUFV2 mRNA, 10 µg of total RNA was 
extracted from brain using Trizol reagent (Invitrogen) and following the 
manufacturer’s instructions. The RNA was annealed to oligo d(T) anchor (200 
ng/µl; 5’ GCGAGCTCCGCGGCCGCGTTTTTTTTTTTT 3’) at 65 °C for 5 min and 
then extended in a cDNA synthesis reaction using Superscript III (Invitrogen) at 
50 °C for 60 min according to manufacturer’s instructions. 1 µl of cDNA template 
along with NDUFV2-specific primer and oligo d(T)anchor were used in a 25 µl 
PCR reaction with GoTaq (Invitrogen).  PCR products were analyzed on 2.5 % 
agarose gels. 
Quantification of dendritic growth  
Hippocampal neurons grown on coverslips were fixed in 4% paraformaldehyde in 
PBS containing 4% sucrose for 20 mins at room temperature at various days in 
vitro (DIV).  Coverslips were washed in PBS, permeabilized in 0.2 % Triton X-100 
for 7 min, blocked in 10% BSA solution and immunostained with anti-alpha 
tubulin (Sigma, 1:1000 dilution).  The neurons were then imaged using Nikon 
ECLIPSE E600 fluorescence microscope.  The length of branches was 
calculated by tracing the dendrites in NeuronJ (plugin in ImageJ) software.  The 
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 amount of branching was determined using the Sholl analysis plugin in ImageJ 
(NIH) software.  Other neurons were supplemented daily with 1 mM 
phosphocreatine on DIV 2,3,4,5 before performing Sholl analysis on DIV 6.  
Construction, production and stereotactic injection of engineered 
retroviruses 
Engineered self-inactivating murine retroviruses were used to express GFP 
specifically in proliferating cells and their progeny.  GFP expression was under 
the control of the eEF1α promoter and the shRNA was co-expressed under the 
control of the human U6 promoter in the same vector. shRNA against mouse 
CPEB (position 1466: gtcgtgtgactttcaataa) was cloned into a retroviral vector 
using a PCR SHAGing strategy. Adult (7-8 weeks old) female C57Bl/6 mice 
(Charles River) housed under standard conditions were anaesthetized (100 µg 
ketamine, 10 µg xylazine in 10 µl saline per gram) and retroviruses were 
stereotactically injected into the dentate gyrus as previously described (Ge et al., 
2006).  Mice were sacrificed at 14 days post infection (dpi) for morphological 
analysis.  Images were acquired on a Carl Zeiss LSM 710 confocal system and 
analyzed using Carl Zeiss Zen software.  For analysis of the dendritic structure of 
neurons, the images were semi-automatically traced with NIH ImageJ using the 
NeuronJ plugin.  Only granule cells with complete dendritic trees that were not 
overlapping with the other infected neurons were used for morphological 
characterization (neurons from 4 to 6 animals per condition were examined.  The 
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 Sholl analysis for dendritic complexity was carried out by counting the number of 
dendrites that cross a series of concentric circles at 20 µm intervals from the 
soma. For ectopic expression of NDUVF2, a retroviral construct encoding for 
NDUVF2 fused to mCherry via a T2A linker was used (Szymczak et al., 2004).  
To determine whether NDUFV2 expression can rescue the dendritic branching 
dysfunction in the CPEB-deficient neurons in vivo, mouse DG were 
stereotactically injected with either of three groups of retroviruses: group 1 
contained viruses expressing shRNA for CPEB and mcherry; group 2 contained 
viruses expressing shRNA for CPEB and wild type NDUFV2; group 3 contained 
viruses expressing shRNA for CPEB and NDUFV2 that lacked its mitochondrial 
targeting sequence (MTS). The neurons were then analyzed as described above.  
Statistical significance (p < 0.001) was determined by 1-way ANOVA with 
Newman-Keuls’ post hoc test.  All animal procedures and applicable regulations 
of animal welfare were in accordance with the Institutional Animal Care and Use 
committee (IACUC) guidelines and were approved by Singhealth IACUC in 
Singapore. 
Statistical analysis 
Data were interpreted using Students t-test and the error bars indicate Standard 
Error of Mean (SEM). Statistical significance was determined by 1-way ANOVA 
with Newman-Keuls’ post hoc test. 
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 Preface to Chapter III 
A large part of the work presented in this Chapter was a collaborative 
effort between Ming Chung Kan (MCK), a former graduate student, and I (AO). 
Nuclear localization of CPEB4 upon NMDA stimulation was discovered by MCK 
but the immunostaining for the same as presented in this chapter was performed 
by AO. CPEB4 localization in dendrites was jointly performed by MCK and AO. 
MCK discovered the various effectors for CPEB4 nuclear localization and 
identified the nuclear localization and export signals. Identification of CPEB 
family members as nucleo-cytoplasmic shuttling proteins was done by MCK. 
Ischemia and Oxygen glucose deprivation studies were also performed by MCK 
in collaboration with Guang Jin in Dr. Klaus van Leyen’s lab. The role of nuclear 
CPEB4 in neuronal survival was revealed by AO. Immunoelectron microscopic 
visualization of CPEB4 on endoplasmic reticulum was performed by Amalene 
Cooper-Morgan, a postdoctoral associate. The importance of endoplasmic 
reticulum calcium reduction as opposed to cytoplasmic calcium increase as the 
main reason for CPEB4 nuclear localization was elucidated by AO.        
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 Abstract 
 
The RNA binding protein CPEB regulates cytoplasmic polyadenylation 
and translation in germ cells and the brain.  In neurons, CPEB is detected at 
postsynaptic sites as well as in the cell body.  The related CPEB3 protein also 
regulates translation in neurons albeit probably not through polyadenylation; it as 
well as CPEB4 is present in dendrites and the cell body.  Here, we show that 
treatment of neurons with ionotropic glutamate receptor agonists causes CPEB4 
to accumulate in the nucleus.  All CPEB proteins are nucleus-cytoplasm shuttling 
proteins that are retained in the nucleus in response to calcium-mediated 
signaling and αCaMKII activity.  CPEB2, 3, and 4 have conserved nuclear export 
signals that are not present in CPEB.  CPEB4 is necessary for cell survival, and 
becomes nuclear in response to focal ischemia in vivo and when cultured 
neurons are deprived of oxygen and glucose.  Further analysis indicates that 
CPEB4 nuclear accumulation is controlled by the depletion of calcium from the 
ER, specifically through the IP3 receptor indicating a communication between 
these organelles in redistributing proteins between subcellular compartments.  
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 Introduction 
 
 The Cytoplasmic Polyadenylation Element Binding (CPEB) protein, a 
sequence-specific RNA binding protein, is found in the cell body and at synapses 
of hippocampal and other neurons; in response to synaptic experience, CPEB 
promotes polyadenylation and translation (Richter, 2007; Wells et al., 2001; Wu 
et al., 1998).  CPEB knockout mice (Tay and Richter, 2001) have deficiencies in 
synaptic plasticity, particularly theta-burst induced long-term potentiation (LTP) 
(Alarcon et al., 2004; Zearfoss et al., 2008), as well as in particular forms of 
hippocampus-dependent memories (Berger-Sweeney et al., 2006).  Some of 
these CPEB-related functions may be related at least in part to its ability to direct 
CPE-containing RNA transport in dendrites (Huang et al., 2003) in addition to its 
regulation of translation (Zearfoss et al., 2008).  
In neurons, most of the CPEB-related proteins CPEB3 and CPEB4 are 
found in the cell soma.  However, a relatively small amount of these proteins is 
localized to synaptic regions and co-fractionate with postsynaptic density 
proteins, suggesting possible roles in RNA translation and/or localization (Huang 
et al., 2006).  While investigating the possible translocation of CPEB3 and 4 to 
dendritic spines in response to N-methyl-D-aspartate (NMDA) receptor activation, 
as is the case with Fragile X mental retardation protein (FMRP) (Ferrari et al., 
2007), we noticed a surprising re-localization of CPEB4 from the cell soma to the 
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 nucleus.  Although the treatment of neurons with ionotropic glutamate receptor 
activating agents such as glutamate and AMPA, as well as NMDA, induced 
nuclear localization of CPEB4, an agonist of the metabotropic glutamate 
receptors, dihydroxyphenylglycine (DHPG), did not.  CPEB4 remained 
cytoplasmic when CaMKII activity was inhibited, suggesting a link between 
calcium levels and nuclear import and/or retention.  When fused to epitope tags 
and expressed in neurons, CPEB, CPEB3, and CPEB4 also became 
concentrated in the nucleus in response to NMDAR activation.  All three proteins, 
however, were also nuclear when neurons were treated with leptomycin B (LMB), 
an agent that inactivates the nuclear export factor, chromosome region 
maintenance 1 (Crm1), indicating that CPEB family proteins are continuously 
shuttling between the nucleus and cytoplasm.  Moreover, these data suggest that 
NMDAR activation does not necessarily induce nuclear translocation, but nuclear 
retention of the CPEB proteins. 
One physiological event that causes widespread glutamate overload is 
ischemia, which occurs when the brain’s supply of glucose and oxygen is 
disrupted by stroke or cardiac arrest (Plum, 1983).  ATP production is reduced 
when the blood supply is insufficient, causing neuron polarization and 
accumulation of glutamate in the extracellular space due to reversed 
uptake(Rossi et al., 2000).  This excess glutamate is responsible for neuron 
death in transient ischemia (Choi and Rothman, 1990), and its stimulation of 
massive calcium influx through the NMDA receptors plays a major role in 
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 excitotoxicity (Tymianski et al., 1993a; Tymianski et al., 1993b).  A mouse model 
for transient focal ischemia caused CPEB4 nuclear accumulation, as did an in 
vitro model for oxygen glucose deprivation.  Lentivirus-mediated shRNA 
knockdown of CPEB4 demonstrates that this protein is essential for neuron 
survival, and might suggest that its nuclear accumulation is a physiological 
response to high levels of intracellular calcium.  However, additional experiments 
with cultured neurons show that the depletion of calcium from the endoplasmic 
reticulum (ER), rather than elevated levels of cytosolic calcium per se, is 
responsible for CPEB4 nuclear accumulation.  We have also demonstrated the 
involvement of IP3 receptors in this ER calcium depletion-mediated nuclear 
accumulation of CPEB4.  We propose that dispatch of a signal, dependent upon 
the expulsion of ER calcium, signals to CPEB4 to accumulate in the nucleus 
where it may offer some protection against cell death. 
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 Results 
 
NMDA induces nuclear localization of CPEB4 
In cultured hippocampal neurons, CPEB4 is detected mainly in the 
cytoplasm and in dendrites; it is also enriched in post-synaptic density (PSD) 
fractions from adult rat brain and hippocampal neurons. To assess if CPEB4 
changes in response to synaptic activity, neurons were treated with 0.1 mM 
NMDA for 40 minutes in the presence of tetrodotoxin (TTX).  Compared to a 
control, NMDA treatment unexpectedly caused strong and permanent nuclear 
CPEB4 immunostaining, which was prevented when APV, an NMDA antagonist, 
was added to the cells (Figure 3.1A and B; see also Figure 3.2 for specificity of 
CPEB4 antibody).  Although TTX was used here to silence spontaneous neural 
activity, we have observed similar nuclear localization of CPEB4 even in the 
absence of TTX (data not shown).The number of neurons in which CPEB4 was 
predominantly nuclear or cytoplasmic, or distributed in both compartments (see 
Figure 3.3 for representative images) as a function of activity shows that NMDA 
caused a dramatic nuclear localization of CPEB4 that was nearly completely 
prevented by APV (Figure 3.1, right panel; comparing TTX vs. TTX+NMDA 
treatment, p<0.01, Student’s t test). Also, upon treatment with lower 
concentrations of NMDA (0.01 mM and 0.001 mM), fewer number of neurons 
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 show nuclear accumulation of CPEB4 (data not shown), thus exhibiting a dose 
response to NMDA. 
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 Figure 3.1 Stimulation of NMDA receptor causes CPEB4 nuclear localization. 
A. DIV16 hippocampal neurons incubated in TTX for 24 hours were treated with 
buffer alone (TTX) or NMDA (TTX+NMDA), and then fixed and immunostained 
with affinity-purified CPEB4 antibody.  DAPI shows nuclear DNA staining.  The 
cells were examined by confocal microscopy.  To quantify the localization of 
CPEB4 in the nucleus or cytoplasm, other cells were stained for CPEB4 where 
the protein was predominantly cytoplasmic, nuclear, or evenly distributed in 
cytoplasm and nucleus (see Figure 3.3 for representative images).  Using this 
protein distribution as a standard, the percent of cells in which CPEB4 was in 
these compartments following TTX, NMDA, treatment was determined 
(histogram).  The asterisks refer to statistical significance (p<0.01, Student’s t 
test) between neurons samples treated TTX versus TTX+NMDA. B. DIV16 
hippocampal neurons incubated in TTX for 24 hours were treated with APV 
(TTX+NMDA+APV) for 5 minutes prior to application of NMDA for 40 minutes 
and then fixed and immunostained with affinity-purified CPEB4 antibody.  DAPI 
shows nuclear DNA staining.  The cells were examined by fluorescence 
microscopy. The asterisks refer to statistical significance (p<0.01, Student’s t 
test). Size bar= 10 µm. 
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 Figure 3.2 Specificity of CPEB4 antibody.  
A. Protein from total brain or testis were separated by SDS-PAGE and blotted on 
PVDF membrane before probing with affinity purified CPEB4 antibody. B. DIV2 
hippocampal neurons were transfected by pLL3.7-syn-C4KD2 or pLL3.7-syn-
C4G5 that expresses shRNA against CPEB4 coding region or 3’UTR 
respectively. Three days after transfection, neurons were fixed and 
immunostained with affinity purified CPEB4 antibody.  
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 Figure 3.3 Examples of subcellular protein distribution patterns.  
Top panel shows the distribution of protein mainly in cytoplasm. Middle panel 
shows equal distribution of protein between nucleus and cytoplasm. Lower panel 
shows the distribution of protein mainly in nucleus.  DAPI staining is used to 
indicate the location of nucleus.  
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 NMDA also caused a substantial loss of CPEB4 from dendrites.  Although 
NMDA did not significantly alter the overall amount of CPEB4 in neurons, it did 
lead to an increase in the fluorescence intensity of CPEB4 in the nucleus relative 
to that in the cell body without stimulation (Figure 3.4).  These data suggest that 
dendritic (and cell body) CPEB4 was not destroyed in an activity-dependent 
manner, but instead was probably transported retrogradely to the nucleus.  
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 Figure 3.4 CPEB4 in dendrites.  
A. CPEB4 levels in dendrites from control (TTX only) or NMDA (plus TTX) 
treated DIV16 neurons; the histogram shows a quantification of the fluorescent 
dendritic signal.  B. Quantification of the CPEB4 fluorescent signal in the cell 
body or nucleus of DIV16 neurons following TTX or TTX + NMDA treatment.  The 
panel also shows a western blot for CPEB4 and actin, as a loading control, from 
neurons treated with TTX or TTX+NMDA as before. 
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 Ligand binding to ionotropic glutamate receptors causes calcium influx 
and induces downstream signaling events through CaMKII (calcium/calmodulin-
dependent protein kinase II) (Hudmon and Schulman, 2002).  To examine 
whether extracellular calcium is important for CPEB4 nuclear accumulation, 
EGTA was applied to neurons before NMDA; this caused CPEB4 to remain 
predominantly cytoplasmic (Figure 3.5A).  To assess whether NMDA/calcium 
induced CPEB4 nuclear accumulation occurs via CaMKII, a membrane-
permeable CaMKII inhibitory peptide, AIPII (Ishida et al., 1998; Watterson et al., 
2001) was applied to neurons 20 minutes before NMDA treatment.  This peptide 
reduced NMDA-induced CPEB4 nuclear translocation (Figure 3.5B), indicating 
that extracellular calcium and CaMKII are part of an NMDA-induced signaling 
pathway that causes CPEB4 nuclear accumulation.  In addition, treatment of 
neurons with glutamate, AMPA or NMDA induced CPEB4 nuclear staining; 
DHPG, a metabotropic glutamate receptor agonist, however, had no effect 
(Figure 3.5B).  These data, together with the determination of the number of cells 
that respond to these treatments (Figure 3.5C), show that ionotropic glutamate 
receptor activation induces CPEB4 nuclear accumulation. 
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 Figure 3.5 Effectors of CPEB4 nuclear localization.   
A.  DIV16 neurons were incubated with EGTA for 20 minutes prior to application 
of NMDA for 40 minutes; the cells were then fixed and stained for CPEB4.  B. 
TTX treated DIV16 hippocampal neurons were treated with DHPG, AMPA, 
glutamate, or NMDA for 40 min before being immunostained with CPEB4 
antibody.  Other cells were treated with AIPII for 20 minutes and then subjected 
to NMDA for 40 minutes before fixation.  C.  Quantification of CPEB4 in the 
cytoplasm, nucleus, or both nucleus and cytoplasm was determined as in Figure 
1. The asterisks refer to statistical significance (p<0.01, Student’s t test) between 
the indicated samples. 
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 CPEB family proteins are nucleus-cytoplasm shuttling proteins 
CPEB4 nuclear accumulation could be due to active cytoplasm-to-nucleus 
import or inhibited nuclear export if this protein continuously shuttles between the 
two compartments.  To distinguish between these possibilities, neurons were 
treated with leptomycin B (LMB), an inhibitor of the nuclear export factor Crm1 
(Kudo et al., 1999; Nishi et al., 1994; Petosa et al., 2004).  Application of LMB to 
cultured neurons resulted in nuclear accumulation of CPEB4, suggesting that 
CPEB4 is a nucleus/cytoplasm shuttling protein (Figure 3.6A).  
To investigate whether other CPEB family proteins are nucleus/cytoplasm 
shuttling proteins and accumulate in the nucleus in response to NMDA, DIV14 
hippocampal neurons were infected with lentiviruses expressing epitope-tagged 
CPEB1, CPEB3, and CPEB4, which were then subjected to either LMB or NMDA 
treatment.  These proteins all accumulated in the nucleus when nuclear export 
was blocked by LMB, suggesting they are all shuttling proteins (Figure 3.6B).  
NMDA treatment also caused these proteins to accumulate in nuclei (Figure 
3.6B; quantification of responsive cells in Figure 3.6C), supporting the notion that 
nuclear accumulation is a common feature among CPEB proteins in neurons 
following synaptic stimulation.  To determine whether CPEB4 nuclear 
accumulation is neuron-specific, we treated HeLa cells and 293T cells with LMB; 
in both cases CPEB4 was retained in the nucleus (unpublished data).  We also 
treated HeLa cells with digitonin, which causes cytoplasmic leakage through 
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 pores in the plasma membrane.  When a fusion of the CPEB4 RNA binding 
domain (RBD, i.e., both RNA cognition motifs – RRMs and both zinc fingers) to 
GST was added to the treated cells after they were washed to remove the leaked 
cytoplasm, there was no evidence of nuclear accumulation.  However, when the 
permeabilized cells were supplemented with fresh HeLa cytosol, nuclear CPEB4-
GST was readily apparent (Figure 3.6D).  These data show that CPEB4 nuclear 
transport is not neuron-specific and that the RBD contains the nuclear 
localization signal (NLS) of CPEB4. 
 
 
 
 
 
 
 
 
 
 
112
 Figure 3.6 CPEB family proteins are nucleus/cytoplasm shuttling proteins.  
 A. DIV 16 hippocampal neurons are treated with 0.1% ethanol alone or with 
10nM LMB for 40 minutes before fixation and immunostained for endogenous 
CPEB4. B. DIV16 neurons infected with lentivirus expressing HA-CPEB, myc-
CPEB3, or myc-CPEB4 for 2 days were treated with 10 nM LMB for 1 hr and 
then immunostained with HA or myc antibodies.  Other infected cells were 
stimulated with NMDA for 1 hour prior to immunostaining.  C.  Quantification of 
CPEB, CPEB3, or CPEB4 in the nucleus or cytoplasm following the treatments 
noted in panel B.  The asterisks refer to statistical significance (p<0.01, Student’s 
t test) between the indicated samples.  D.  Hela cells were treated with digitonin 
and the permeabilized cells were incubated with an ATP regenerating system, 
purified recombinant GST-CPEB4RBD fusion protein and with or without HeLa 
cell cytosol.  After 40 min, the cells were fixed and stained with GST antibody. 
Size bar=10 µm. 
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 Identification of CPEB4 nuclear import/export cis-elements 
 To identify the CPEB4 NLS and nuclear export signal (NES), plasmids 
encoding serial deletions of CPEB4 (D1-D7) were generated (Figure 3.7A) and 
transfected into NIH3T3 cells, which because of their flattened morphology, are 
particularly amenable for use in immunocytochemistry to distinguish between 
cytoplasmic and nuclear proteins.  A CPEB4 truncation mutant that lacks the 
NLS would be expected to be constitutively cytoplasmic irrespective of LMB 
treatment; protein with an NES deletion should reside in the nucleus irrespective 
of LMB treatment. 
 Although the entire CPEB4 protein was sequentially deleted (Figure 3.7A), 
none of the mutants remained cytoplasmic when cells were treated with LMB.  
Thus, CPEB4 probably has two or more independently acting NLSs.  However, 
CPEB4 truncation mutant D4, lacking residues 351-463, was nuclear in the 
absence or presence of LMB, indicating this truncated region contains the NES 
(Figure 3.7B; quantification of responsive cells presented in Figure 3.7C).  The 
expression levels of the CPEB4 mutant proteins are shown in the lower right 
panel of Figure 3.7B.   
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 Figure 3.7 Identification of the CPEB4 shuttling elements.   
A.  The CPEB4 internal deletion constructs are depicted.  The boxes indicate the 
parts of the protein that were deleted and the grey boxes indicate the known 
functional domains (RRM1, RRM2, ZF) of CPEB4.  The bar in N-terminus is a 
myc epitope tag.  RRM1 and RRM2 refer to RNA recognition motifs 1 and 2; ZF 
refers to two zinc fingers.  B.  NIH3T3 cells were transfected with plasmid DNA 
encoding the proteins shown in panel A; 12 hours later, the cells were treated 
with LMB for 1 hr prior to fixation.  Antibody against the myc epitope was used for 
immunostaining.  Exogenous proteins and alpha-tubulin were monitored by 
immunoblotting. Size bar=10 µm.  C. Quantification of the CPEB4 proteins in the 
nucleus, cytoplasm as in Figure 3.1. The asterisks refer to statistical significance 
(p<0.01, Student’s t test) between the indicated samples. 
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 Using the Multalin program (Corpet, 1988) that compares protein 
sequence similarity,  a sequence from the peptide deleted in mutant D4 was 
aligned with corresponding regions from CPEB2, 3, and 4 from rat, human, 
Xenopus, zebrafish, and Drosophila (in this case, a single CPEB4-like protein is 
called Orb2).  Figure 3.8A shows that CPEB4 residues 383-397 within the 
deleted peptide are highly conserved among all the protein sequences examined.  
Leucine residues are often found in NESs; mutation of two of them at positions 
385 and 390 (arrows and denoted in bold) to alanine (CPEB4 LL/AA) caused the 
accumulation of CPEB4 in the nucleus of transfected 3T3 cells irrespective of 
whether they were treated with LMB (Figure 3.8A lower left; quantification of cells 
in 5A lower right).  Thus, these leucine residues are essential for CPEB4 nuclear 
export.  To assess sufficiency of nuclear export, various segments of CPEB4 
containing the NES were fused to EGFP-MS2, which also contained a SV40 T 
NLS (N-EGFP, Figure 3.8B).  As expected, the control N-EGFP lacking a CPEB4 
NES was nuclear in transfected 3T3 cells (Figure 3.8B, middle left panel).  Upon 
fusion with the CPEB4 NES-containing fragment, three of the fusion proteins, N-
EGFP-268, N-EGFP-145, and N-EGFP-83, became localized to the cytoplasm in 
the absence but to the nucleus in the presence of LMB.  However, two proteins 
lacking CPEB4 residues 341-376 (N-EGFP-110 and N-EGFP-48) were evenly 
distributed to both nuclear and cytoplasmic compartments, suggesting a lack of 
NES function (Figure 3.8B middle; quantification of cells in bottom panel).  From 
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 these results, we conclude that CPEB4 residues 341 to 424 constitute a minimal 
NES.  
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 Figure 3.8 Identification of CPEB4 nuclear export signal.   
A.  Alignment of the human CPEB4 protein sequence from residues 383 to 
397 with homologous regions from rat and zebrafish CPEB4 and human and 
Xenopus CPEB2 and CPEB3 as well as Drosophila Orb2. Two arrows point to 
conserved leucine residues that have been mutated to alanine in the LL-AA 
mutant.  NIH3T3 cells were transfected with DNA encoding myc-tagged wild type 
or LL-AA mutant CPEB4 proteins for 12 hours, treated with LMB for 1 hour and 
then fixed and immunostained for the myc-tagged protein. Quantification of the 
CPEB4 proteins in the nucleus, cytoplasm as in Figure 3.1. The asterisks refer to 
statistical significance (p<0.01, Student’s t test) between the indicated samples.  
B.  Fusion proteins used to identify the minimal CPEB4 NES domain.  Various 
regions of the CPEB4 coding region (the numbers refer to amino acid residue) 
that contain the NES were fused to the SV40 T NLS, the bacteriophage MS2 
coat protein, and EGFP.  The dark bar indicates the leucine residues indicated in 
panel A (top).  NIH3T3 cells were transfected with DNA encoding the fusion 
proteins noted above.  The left panel shows that the NLS-EGFP-MS2 protein, 
without any CPEB4 sequence, was nuclear.  The other panels show the 
nuclear/cytoplasmic distribution of the fusion proteins in neurons, some of which 
were treated with LMB. Size bar=10 µm.  The bottom portion shows the 
quantification of the GFP-CPEB4 fusion proteins in the nucleus or cytoplasm as 
in Figure 3.1. The asterisks refer to statistical significance (p<0.01, Student’s t 
test) between the indicated samples. 
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 Brain ischemia causes CPEB4 nuclear accumulation 
Glutamate plays dual roles in the brain: at physiological levels it induces 
excitatory synapse activation and plasticity; under pathological conditions such 
as ischemia and epilepsy, elevated levels of extracellular glutamate cause 
neuron degeneration through excitotoxicity.  To determine whether CPEB4 
nuclear accumulation is induced by glutamate release in vivo, brain sections from 
rats subjected to high frequency stimulation (HFS) for 90 min were probed with 
CPEB4 antibody.  While this HFS paradigm induced the expression of the 
immediate early gene, activity regulated cytoskeleton-association protein (Arc), in 
granular cells of the dentate gyrus (Steward et al., 1998), it did not cause CPEB4 
nuclear accumulation (unpublished data).  
To investigate whether pathological levels of glutamate or the stress 
associated with it might cause CPEB4 nuclear accumulation, we turned to a 
mouse model for transient focal ischemia.  In this paradigm, the middle cerebral 
artery is occluded (MCAO), which causes a focal deprivation of blood flow for 90 
minutes, followed by a reperfusion of blood for 24 hours before sacrifice and 
histological preparation (van Leyen et al., 2006).  A clear infarction was evident in 
the ipsilateral portion of the brain, which not only caused neuron death (as 
determined by TUNEL staining), but also dramatically reduced CPEB4 staining 
(Figure 3.9A). However, in the motor cortex (Ipsi-MC) and insular cortex (Ipsi-IC), 
which are in the penumbra of the severely affected area, CPEB4 staining was 
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 enriched in the nucleus.  In contrast, CPEB4 staining was cytoplasmic in the 
corresponding contralateral regions (Figure 3.9B).  
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 Figure 3.9 Ischemia causes CPEB4 protein to become concentrated in the 
nucleus. 
A.  Frozen section of the brain taken from mouse that had a middle cerebral 
artery occlusion (MCAO) was fixed and stained for CPEB4. Consecutive section 
from same animal was labeled by TUNEL staining.  The white boxes refer to 
regions of the motor cortex (MC) and insular cortex (IC) that were examined 
under higher magnification in panel B. Size bar=1mm. B. Section from ischemic 
brain was immunostained with anti-CPEB4 antibody. DAPI staining shows nuclei.  
The images were taken from the motor cortex (MC) or insular cortex (IC); 
ipsilateral (Ipsi) and contralateral sides (Con) of these regions are shown.  Size 
bar=20 µm. 
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 Ischemia not only causes hypoxia, but also hypoglycemia in the affected 
part of the brain.  One cell culture model that mimics these two ischemia-induced 
deficits is oxygen glucose deprivation (OGD); here, neurons are cultured under 
conditions of reduced atmospheric oxygen and glucose.  Hippocampal neurons 
(14 DIV) were subjected to OGD treatment for one hour and then returned to 
normal culture conditions for 3 hours before fixation and staining for CPEB4 and 
apoptosis.  In control cells grown under normal conditions, CPEB4 was 
cytoplasmic and TUNEL staining was absent (Figure 3.10A).  After one hour of 
OGD treatment and three hours of recovery, CPEB4 protein was undetectable in 
most neurons but in others, it was concentrated in the nucleus.  Interestingly, 
CPEB4 nuclear staining was inversely correlated with TUNEL staining (Figure 
3.10A right panel), suggesting that nuclear CPEB4 may offer some protection 
against apoptosis. The above mentioned MCAO and OGD experiments suggest 
that excessive glutamate causes CPEB4 nuclear accumulation. However, this 
nuclear accumulation could be due to stress caused by the excessive glutamate.   
To investigate whether CPEB4 is important for neuron survival, cultured 
hippocampal neurons were infected with lentiviruses expressing GFP as well as 
two different shRNAs to knockdown (KD) CPEB4.  Figure 3.10B shows that while 
the KD2 shRNA effectively reduced CPEB4 levels, KD3 did not.  Neither shRNA 
affected CPEB3 or tubulin levels.  Neurons were doubly infected with viruses 
expressing KD2 shRNA and CPEB4 (C4) or CPEB4 ΔNES (C4 ΔNES). C4 and 
C4 ΔNES were mutated to maintain proper amino acid sequence but not to 
126
 anneal with the shRNA.  C4 ΔNES expresses a CPEB4 protein that resides 
solely in the nucleus. Most neurons died when CPEB4 was reduced (KD2 
shRNA), but survived up to three days when CPEB4 levels were restored with 
either full length C4 or C4 ΔNES (Figure 3.10C).  Thus, CPEB4 (specifically 
nuclear CPEB4) is necessary for neuron survival. 
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 Figure 3.10 Oxygen glucose deprivation and CPEB4-mediated neuron survival.  
A. CPEB4 nuclear localization in DIV14 hippocampal neurons after OGD 
treatment. Hippocampal neurons were incubated in medium without glucose in 
an atmosphere deprived of oxygen for 1 hour (OGD 1 hr), which was followed by 
recovery in normal culture media in atmosphere containing oxygen for 3hrs 
(OGD 1hr, recovery 3 hr).  Control (Con) refers to cells without OGD treatment.  
The images show CPEB4 staining, TUNEL staining, CPEB4/TUNEL/DAPI 
staining to show the location of nuclei.  The panel on right shows quantification of 
the CPEB4 proteins in the nucleus, cytoplasm as in Figure 1. The asterisks refer 
to statistical significance (p<0.01, Student’s t test) between the indicated 
samples.  B.  Hippocampal neurons were cultured with lentivirus expressing GFP 
only (V), or GFP and two different CPEB4 shRNAS (KD2, KD3).  Some neurons 
were also cultured with two lentiviruses expressing KD2 and CPEB4 or CPEB4 
ΔNES (C4 or C4 ΔNES, containing mutations to prevent knockdown but still 
encoding the correct protein).  Extracts from the cells were probed for CPEB4, 
CPEB3, tubulin, and GFP.  C.  Survival of the neurons infected with some of the 
viruses noted above was determined (n=200). Error bars represent standard 
error of mean. 
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 CPEB4 is present on ER and its nuclear localization is induced by ER 
calcium depletion 
Transient ischemia induces protein aggregation in the ER, possibly due to 
inhibited folding capacity when luminal calcium levels are reduced (Hu et al., 
2000).  This possibility suggests that CPEB4 nuclear accumulation might also be 
mediated by reduced ER calcium, consequently, a membrane permeable calcium 
chelator, BAPTA-AM, was used to immobilize free calcium inside the ER.  
Twenty minutes after BAPTA-AM addition, neurons were placed in fresh media 
for an additional 40 minutes.  After the membrane permeable moiety of BAPTA-
AM is cleaved by cytosolic esterases, the remaining BAPTA becomes trapped 
intracellularly.  Because the dissociation constant of BAPTA for calcium is close 
to cytosolic calcium level, BAPTA does not substantially affect cytosolic calcium 
levels (Paschen et al., 2003).  On the other hand, BAPTA targets free calcium in 
the ER because of its high calcium level (~700µM) (Demaurex and Frieden, 
2003).  This chelation of ER calcium induced the nuclear accumulation of CPEB4 
(Figure 3.11A).  
A reduction in ER calcium diminishes protein chaperone activity in the 
lumen, causing the accumulation of unfolded protein that will induce the ER 
stress response (Paschen et al., 2003).  To determine whether CPEB4 nuclear 
accumulation is a response to ER calcium depletion or ER stress, cells were 
incubated with thapsigargin (TG) and tunicamycin (TM).  Although both agents 
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 activate the unfolded protein response (UPR), TG does so by causing ER 
calcium efflux while TM disrupts protein glycosylation.  In neurons treated with 16 
µM TG, CPEB4 protein began to accumulate in the nucleus 30 minutes after drug 
application (Figure 3.11B).  However, CPEB4 remained cytoplasmic when cells 
were treated with TM although the UPR response did occur as determined by the 
expression of C/EBP homology protein (CHOP) (Figure 3.11C).  These data 
suggest that CPEB4 nuclear accumulation is induced by ER calcium depletion.  
A dose-response experiment demonstrates that while a 1 hour treatment of 4 µM 
TG had no effect on CPEB4 localization, 8 µM caused an even distribution 
between nucleus and cytoplasm while 16 µM TG caused strong nuclear CPEB4 
staining (Figure 3.11D). These data are consistent with the notion that the 
retention of CPEB4 in the nucleus is triggered by ER calcium depletion. 
To investigate how ER calcium depletion might stimulate CPEB4 nuclear 
localization, mouse brain lysate was underlain on a discontinuous sucrose 
gradient and then centrifuged; molecules associated with membranes in such a 
flotation assay should band at a sucrose concentration with a similar density.  
Figure 3.11E shows that Protein Disulfide Isomerase (PDI), an ER specific 
marker banded in fractions 8-10; CPEB4 was most prevalent in fractions 8 and 9.  
The material in these fractions was then pelleted and analyzed by immuno-
electron microscopy using CPEB4 antibody.   Gold particles marking CPEB4 
were found to co-localize with ER structures, thus confirming presence of CPEB4 
on ER (Figure 3.11E).  Although we do not know what other molecules might be 
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 involved in tethering CPEB4 to the ER, we surmise that calcium depletion from 
this structure releases CPEB4 and facilitates its nuclear localization.  
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 Figure 3.11 Relationship between ER calcium levels and CPEB4 nuclear 
localization in cultured hippocampal neurons.  
A. DIV16 hippocampal neurons that had been treated with TTX for 24 hours were 
incubated with BAPTA-AM for 20 min.  The neurons were then washed, cultured 
in fresh media, and then treated with either DMSO or NMDA for 40 min before 
fixation and immunostaining for CPEB4. B. DIV16 hippocampal neurons were 
treated with DMSO as control, or 16 µM thapsigargin (TG) for 30 min or 1 hour. 
At the end of treatment, neurons were fixed and stained with CPEB4 antibody 
and DAPI. C. DIV16 Hippocampal neurons were treated with tunicamycin for 1 
hour, 4 hours or 6 hours before fixation and immunostained with CPEB4 or 
CHOP antibodies. D. DIV16 hippocampal neurons were treated with 4, 8 or 16 
µM thapsigargin for 1 hour before fixation and immunostaining for CPEB4.  DAPI 
staining shows location of the nucleus.  Size bar=10 µm.  E. Sucrose gradient 
fractionation was performed on post-nuclear supernatants of brain lysates; the 
fractions were immunoblotted for CPEB4 and ER marker PDI.  The CPEB4 
enriched fractions (fractions 8-10) were then analyzed by immunoelectron 
microscopy using CPEB4 antibody. Size bar = 200 nm. 
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 We have conducted several additional experiments to delve further into 
the notion that CPEB4 nuclear accumulation is driven substantially by ER 
calcium depletion as opposed to an increase in cytosolic calcium.  Because the 
various agents used in this study to alter calcium levels would likely do so to 
varying extents, we measured relative intracellular calcium levels with Fluo-3, a 
calcium sensitive fluorescent indicator.  DIV16 neurons were incubated with Fluo-
3 followed by treatment with each agent (NMDA, Ionomycin, BAPTA-AM, 
thapsigargin); fluorescence intensity was then determined using a fluorescence 
plate reader.  Figure 3.12A shows that a high intracellular calcium concentration 
per se did not induce CPEB4 to become predominantly nuclear, indeed, BAPTA-
AM, which reduced cytosolic calcium, resulted in nuclear CPEB4.  In this case, 
chelation of ER calcium was most likely responsible for CPEB4 nuclear 
accumulation.  Taken together, these data indicate that the reduction of ER 
calcium stores, and probably not an increase in cytosolic calcium per se, is 
responsible for CPEB4 nuclear accumulation. 
We next determined the extent to which some of the agents that cause 
CPEB4 nuclear accumulation induce ER calcium depletion.  To address this, 
neurons were transfected with D1ER, a plasmid devised by (Palmer et al., 2004) 
that encodes an ER localization signal (derived from calreticulin), cyan 
fluorescent protein (CFP), calmodulin, M13 calmodulin-binding peptide, yellow 
fluorescent protein (YFP), and a KDEL ER retention sequence.  In the ER lumen, 
calcium binding by calmodulin will cause it to also bind the M13.  This interaction 
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 will induce a conformational change in the fusion protein such that CFP and YFP 
will be juxtaposed.  When transfected neurons are excited by 440 nm light, YFP 
(the acceptor) will emit a 535 nm FRET signal.  The intensity of the 535 nm 
signal is therefore proportional to the amount of calcium that is bound to 
calmodulin ((Palmer et al., 2004); Figure 3.12B,).  To first “calibrate” the FRET 
signal, the intensity of 535 nm light emission from untreated cells was set at zero 
(i.e., Rmax, maximal ER calcium), and that from cells treated with ionomycin plus 
EGTA set at -100 (i.e., Rmin, minimum ER calcium).   The data collected from 
cells treated with various agents were then plotted as percent ER calcium 
change (Figure 3.12C).  As expected, NMDA treatment indeed caused a loss of 
ER calcium, as did thapsigargin and BAPTA-AM, although to varying extents 
(Figure 3.12C).  Thus, agents that cause CPEB4 to concentrate in the nucleus do 
indeed induce depletion of ER calcium (see also Figure 3.13). 
Finally, we addressed whether the IP3 receptor, which resides 
predominantly in the ER, can mediate ER calcium depletion and transduce a 
signal to cause CPEB4 nuclear accumulation.  Neurons were treated with 2-
aminoethoxydiphenyl borate (2-APB), an inhibitor of IP3 receptor signaling, with 
or without NMDA.  Figure 3.12D shows that 2-APB partially blocked NMDA-
induced CPEB4 nuclear accumulation.  Thus, implicating IP3 receptor  in  
mediating the subcellular localization of CPEB4 in response to depletion of 
calcium from the endoplasmic reticulum.  
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 Figure 3.12 ER Calcium depletion causes CPEB4 to be retained in the nucleus.   
A.  DIV16 neurons were loaded with 1 µM Fluo-3/AM for 30 minutes and then 
incubated for another 30 minutes to allow for de-esterification before being 
treated with the agents noted in the panel.  The cells were then placed in a 
fluorescence plate reader to quantify Fluo-3 fluorescence, a relative measure of 
calcium concentration.  B.  Schematic structure of the D1ER cameleon construct 
showing an ER targeting sequence, CFP, calmodulin (CaM, the calcium binding 
domains are depicted as balls with a putative flexible coiled region in between), 
M13 calmodulin binding peptide, YFP, and a KDEL ER retention sequence.   
When the calmodulin moiety binds calcium in the ER it interacts with the M13 
peptide, which in turn brings CFP and YFP into close proximity.  An excitation at 
440 nm elicits a 535 nm FRET emission from the YFP; this FRET signal is thus 
proportional to the amount of calcium the ER.  C. DIV12 neurons were 
transfected with pD1ER cameleon construct, the FRET and CFP signals were 
determined. The maximum and minimum FRET/CFP signals were measured 
when the cells were untreated or treated with ionomycin and EGTA, and were set 
at 0 and -100, respectively.  The percent of ER calcium change has been plotted 
(see also Palmer et al, 2004).  ER calcium was determined when the cells were 
treated with NMDA, ionomycin, thapsigargin, or BAPTA-AM.  Each experiments 
was performed 3 times (mean and SEM are shown). D. DIV 16 neurons were 
incubated with 2-APB for 45 mins prior to application of NMDA for 40 mins; the 
cells were then fixed and stained for CPEB4. Panel on the right shows 
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 quantification for the same. The asterisks refer to statistical significance (p<0.01, 
Student’s t test) between the indicated samples.  Size bar= 10 µm.  
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 Figure 3.13 Effect of Ionomycin on CPEB4 localization.  
DIV16 neurons were treated with ionomycin (5 µM) for 1 hour before 
immunostaining for CPEB4.   
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 Discussion 
 
Most investigations of the biological functions of CPEB, the most studied 
member of the CPEB family of proteins, have concentrated on cytoplasmic 
events such as cytoplasmic polyadenylation, translation, and RNA transport.  The 
finding that the CPEB proteins are nucleus/cytoplasm shuttling proteins suggests 
new functions for these proteins involving nuclear RNA metabolism.  For 
example, the CPEB interacting proteins CPSF and symplekin are involved in 
nuclear pre-mRNA polyadenylation as well as cytoplasmic polyadenylation 
(Hofmann et al., 2002; Mandel et al., 2006); thus, it is possible that CPEB may 
also modulate nuclear polyadenylation as well as alternative splicing (Lin et al., 
2010).  Another possible role for CPEB proteins is RNA nuclear export and 
subcellular localization.  Unlike Staufen2 and She2, two nucleus/cytoplasm 
shuttling proteins that accumulate in nucleoli when RNA binding activity is 
disrupted (Du and Richter, 2005; Macchi et al., 2004), CPEB4 truncation mutants 
that have part of their RNA binding domains removed retain their shuttling 
activity, suggesting that it is actively transported across the nuclear membrane 
instead of passively exported by way of tethering to RNA. 
  The failure to identify a nuclear import signal (NLS) in CPEB4 using serial 
deletions suggests that there is more than one NLS.  One putative NLS is 
probably located in an RNA binding domain because recombinant CPEB4 RNA 
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 binding domain alone is sufficient to induce nuclear import in the presence of 
HeLa cell cytosol in an in vitro import assay.  On the other hand, the CPEB4 NES 
clearly requires leucine residues 386 and 390.  Because these residues are 
present in CPEB2 and 3, they probably mediate the export of these proteins as 
well.  Moreover, because they are conserved in, for example, Drosophila Orb2, 
we infer that they have a similar function in invertebrates as well.  The 
observation that the two leucine residues are not present in CPEB underscores 
the divergent nature of these two branches of the CPEB family of proteins.  
Nonetheless, the fact that CPEB, like CPEB2, 3, and 4 shuttles between nucleus 
and cytoplasm in an NMDA-stimulated manner indicates that they have retained, 
and perhaps even share, important nuclear functions. 
CPEB4 is retained in the nucleus following ischemia  
 The nuclear staining of CPEB4 in the penumbra region of the mouse 
ischemic brain demonstrates that this pathological condition causes a subcellular 
re-distribution of this protein.  The penumbra represents the area of brain that 
sustains secondary damage caused by the diffusion of glutamate and potassium 
ions from the immediate site of the infarct, as well as hypoperfusion; it is also a 
target of treatment that aims to reduce brain injury caused by stroke.  In addition 
to CPEB4, other proteins have also been shown to translocate to the nucleus 
upon ischemia.  One of them, apoptosis inducing factor (AIF), resides in 
mitochondria and functions as an oxido-reductase in cells but translocates to the 
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 nucleus and induces chromatin condensation when apoptosis or necrosis is 
induced (Daugas et al., 2000; Susin et al., 1999).  During ischemia and OGD, 
nuclear translocation of AIF is considered to be one of the mechanisms that 
cause neuron death (Cao et al., 2003; Plesnila et al., 2004; Zhao et al., 2004; 
Zhu et al., 2003).  HGF (hepatocyte growth factor), which protects neurons from 
ischemia induced cell death when perfused into the brain, prevents the 
translocation of AIF to the nucleus (Niimura et al., 2006).  
Excessive NMDAR activation and ER calcium depletion 
 To examine the relationship between CPEB4 nuclear accumulation and 
cellular calcium, we treated cells with a variety of agents and then measured 
intracellular calcium concentration with Fluo-3AM, a cytosolic calcium indicator.  
In general, agents that induce increased calcium correlated with CPEB4 nuclear 
accumulation.  However, BAPTA-AM, which resulted in CPEB4 nuclear 
accumulation, did not lead to any detectable increase in cellular calcium.  On the 
other hand, the BAPTA-AM results are consistent with a decrease in ER calcium.  
Moreover, because the relationship between excessive NMDAR stimulation and 
(possible) ER calcium depletion is not clear, we examined ER calcium levels in 
neurons directly by fluorescence resonance energy transfer (FRET).  In this 
case, neurons were transfected with a plasmid (cameleon D1ER) encoding a 
fluorescent calcium sensor specifically targeted to the ER (Palmer et al., 2004).  
Upon treatment with NMDA, ionomycin, thapsigargin, and BAPTA-AM, agents 
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 that cause CPEB4 to become concentrated in the nucleus, we observed clear 
decreases in ER calcium (Figure 3.12).  While the amount of ER depletion varied 
depending on the agent, the correlation between nuclear CPEB4 immunostaining 
and ER calcium depletion was very consistent.  Thus, based on these direct 
measurements, we infer that ER calcium depletion is responsible for CPEB4 
nuclear accumulation. 
 It has been shown that ER stress is induced in ischemic tissue as 
demonstrated by the accumulation of misfolded proteins (Hu et al., 2000) and 
induction of the UPR pathway (Morimoto et al., 2007).  The UPR is induced by 
decreased ER folding capacity or increased synthesis of proteins that transit 
through the ER.  Although it has been suggested that calcium depletion may be 
responsible for ER stress after ischemia, no clear evidence has been provided.  
In our results, both ER calcium depletion and NMDA application caused CPEB4 
nuclear accumulation; we further demonstrate that NMDAR activation causes ER 
calcium depletion, indicating a causal relationship.  It has been reported that 
activation of NMDAR may induce the release of calcium from the ER through 
calcium induced calcium release (CICR) (Emptage et al., 1999; Rose and 
Konnerth, 2001).  In neurons, the ER forms an extended structure that reaches 
synaptic spines (Svoboda and Mainen, 1999) and contains two types of calcium 
releasing channels, the inositol-1,4,5-trisphosphate receptor (IP3) and the 
ryanodine receptor.  Another report also suggests that the ryanodine receptor 
may cause ER calcium release because application of a ryanodine receptor 
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 inhibitor, dantrolene, protects neurons from NMDA mediated excitotoxicity 
(Frandsen and Schousboe, 1992).  Caffeine, which activates the ryanodine 
receptor did not cause CPEB4 nuclear accumulation probably because it did not 
cause sufficient ER calcium depletion and/or its well known pleiotropic effects.  
On the other hand, inhibition of the IP3 receptor with 2-aminoethoxydiphenyl 
borate (2-APB) blocked NMDA-induced CPEB4 nuclear accumulation, indicating 
that the IP3 receptor is of particular importance for causing CPEB4 to remain 
nuclear.  
Mechanism for ER calcium depletion induced CPEB4 nuclear retention 
The treatment of neurons with TG but not TM excludes ER stress per se 
as a possible mechanism for inducing CPEB4 nuclear accumulation.  The 
retention of CPEB4 in the nucleus after BAPTA-AM incubation suggests that ER 
calcium depletion plays an inhibitory role in CPEB4 nuclear export.  One key 
extant question is how does ER calcium depletion induce CPEB4 retention in the 
nucleus?  Recent investigations of ER calcium homeostasis suggest that store 
operated calcium entry (SOCE) replenishes ER calcium levels after depletion.  
SOCE involves two protein families: the stromal interacting molecule (Stim) 
family and plasma membrane calcium channels, Orai.  Stim proteins are located 
in the ER membrane and serve as ER lumen calcium level sensors (Roos et al., 
2005; Zhang et al., 2005).  Orai channel proteins interact with aggregated stim 
proteins and induce calcium influx when ER calcium is depleted (Feske et al., 
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 2006; Luik et al., 2006; Mercer et al., 2006; Peinelt et al., 2006; Prakriya et al., 
2006).  The influxed cytoplasmic calcium is then transported into the ER by the 
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) system (Jousset et al., 
2007).  Whether calcium influxed through SOCE triggers CPEB4 nuclear 
retention upon ER calcium depletion and NMDA stimulation requires further 
investigation. 
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 Materials and methods 
 
Hippocampal neuron culture 
The culture of primary rat hippocampal neurons was performed as described 
(Banker and Goslin, 1988) with a typical plating density of 1.8 x 104 cells/cm2 
cultured in Neurobasal media (Invitrogen) containing B27 supplement (B27 
media) and glutamine (1 µg/ml).  Cytosine arabinoside (Ara-C) (1 µ M) was 
added at DIV3 to prevent glial cell proliferation.  
 
Lentiviral vector construction and virus production 
Lentivirus expressing CPEB3 and CPEB4 were constructed by inserting myc-
CPEB3 and myc-CPEB4 into the BamHI and XhoI sites of pFugw vector 
(Addgene).  For virus production, 10 µ g of virus transfer vector that express 
various CPEBs, 7.5 µ g gag-pol expressing vector, psPAX2 (from Addgene) and 
5 µ g VSV-G expressing vector, pMD2.G (from Addgene) were co-transfected 
into 1X107 293T cells plated in 10 cm culture dishes using Lipofectamine 2000 
(Invitrogen).  Three hours after transfection, the medium was replaced with 
Neurobasal medium containing B27 supplement (B27 media).  Forty-eight hours 
after transfection, the medium was collected and passed through a 0.45 mm 
filter; the virus titer in the filtrate was calculated by serial dilution to determine the 
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 minimum amount of virus that can infect 90% of neurons plated at 1.8 x 104 
cells/cm as assayed by immunocytochemistry for the myc-tagged fusion proteins.  
CPEB4 knockdown 
Lentiviruses expressing shRNA against CPEB4 (pLL3.7-syn-KD2 and pLL3.7-
syn-KD3) followed the procedure of (Huang et al., 2006).  The primers for 
constructing pLL3.7-syn-KD2 were C4-KD2-F: 
TGGCTGCAGCATGGAGAGATAGATTTCaagaGaATCTATCTCTCCATGCTG 
CAGCCTTTTTTC and C4-KD2-R: 
TCGAGAAAAAAGGCTGCAGCATGGAGAGATAGATTC 
TCTTGAAATCTATCTCTCCATGCTGCAGCCA. The primers for constructing 
pLL3.7-syn-KD3 were C4-KD3-F: 
TGGCTGCCTCATTTGGCGAATAATTTCaagaGaATTATTCGCC 
AAATGAGGCAGCCTTTTTTC and C4-KD3-R: 
TCGAGAAAAAAGGCTGCCTCATTTGGC 
GAATAATTCTCTTGAAATTATTCGCCAAATGAGGCAGCCA.  Lentivirus 
expressing shRNA was produced by transfecting 293T cell (1X106 cells/ml) with 
transfer vector together with packaging vectors, pSPAX2 and pMD2.G using 
lipofectamine 2000. Three hours after transfection, the cells were washed and 
cultured 48 hours after transfection, when the culture media was collected and 
filtered through a 0.2 mm syringe filter.  The virus containing media was used 
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 directly without concentration; the titer was determined as the minimal amount 
needed to infect more > 90% of cultured neurons.  
Image acquisition and processing 
A Nikon ECLIPSE E600 microscope is used to take fluorescence images; 
confocal images were acquired using a spinning disk confocal microscope 
(CSU10B, Solamere Technology Group) controlled by Metamorph software.  
Most of the images were taken using Plan Flour objective lens with 20 fold 
magnification and numerical aperture (N.A.) of 0.5. Cool charged CCD camera is 
made by Diagnostic instruments Inc (RT color). Images were taken and further 
processed using software SPOT version 3.5.8. Where indicated, fluorescence 
intensity was quantified using Image J software (NIH).  
Antibodies and immunohistochemistry 
CPEB4 antibody was produced as described (Huang et al., 2006); HA (16B12) 
and myc (9E10) monoclonal antibodies were produced as ascites fluid 
(Covance), and CHOP antibody was purchased from Santa Cruz Biotechnology.  
A TUNEL assay kit was purchased from MBL international.  For CPEB4 
immunostaining, cells were fixed in 2% paraformaldehyde/PBS/4% sucrose for 
20 min and then blocked in 10% BSA for 20 min before overnight incubation with 
affinity purified CPEB4 antibody at 4oC.  Secondary antibody (Alexa 595 
conjugated goat anti-rabbit and Alexa 488 conjugated goat anti-mouse), 
application and washing were performed as described (Molecular Probe).  For 
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 some experiments, neurons treated with TTX or TTX plus NMDA were collected 
and probed for CPEB4 and actin on western blots. 
Middle cerebral artery occlusion (MCAO) and oxygen glucose deprivation 
(OGD) 
MCAO was performed as described (van Leyen et al., 2006), except that MCAO 
was extended to 90 min and reperfusion to 24 hours before sacrifice.  For OGD, 
MEM media is purged with nitrogen for 20 minutes to remove oxygen from 
solution. Gas purged media was placed in an anaerobic chamber for 30 mins to 
equilibrate pH. DIV14 hippocampal neurons were then cultured in oxygen 
purged, glucose-deficient MEM media in anaerobic chamber with an air mixture 
of 0.5% oxygen, 10% carbon dioxide and 89.5% nitrogen for 1 hour.  The cells 
were then moved to normal neurobasal medium with B27 and cultured under 
standard conditions for various times before fixation.  
In vitro nuclear import assay 
HeLa cells grown on Lab-Tek Chamber Slides were permeabilized by digitonin 
(40mg/ml) in TB buffer (20 mM HEPES, pH7.4, 110 mM KOAc, 2 mM Mg(OAc)2, 
2 mM DTT, 1 mM EGTA and protease inhibitor) for 5 min on ice.  The cells were 
then washed with TB buffer plus BSA (10 mg/ml) twice.  After the second wash, 
the import reaction mixture was added (2ul 100 mg/ml BSA, 8 ml HeLa cytosol 
with ATP regeneration system, 2 ml GST-CPEB4RBD and 8 ml TB buffer).  The 
ATP regeneration system contained 1 mM ATP, 5 mM phosphocreatine and 20 
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 units/ml creatine phosphokinase.  Permeabilized HeLa cells were incubated in a 
nuclear import reaction for 20 min at 25 oC; the cells were then washed with cold 
TB buffer before fixation with 4% formaldehyde/PBS for 10 mins.  The fixed cells 
were stained with anti-GST antibody to detect nuclear import substrate and 
counterstained with DAPI.  
Pharmacological treatment of primary neuron culture 
Freshly prepared glutamate (100 µM), NMDA (100 µM), AMPA (300 µM), DHPG 
(100 µM) or ionomycin (5 µM) were applied to DIV16 hippocampal neurons for 1 
hr before fixation and immunostaining.  In some experiments, APV (2-amino-5-
phosphonovaleric acid, 20 µM), Ant-AIP-II (Calbiochem, 10 µM), EGTA (2mM) 
were added to the cells 20 min before NMDA.  BAPTA-AM (Calbiochem, 50 µM) 
was added to cultures for 20 min and then replaced with culture media for 40 
min.  Thapsigargin (Calbiochem, 2 mM stock) and tunicamycin (Calbiochem, 5 
mg/ml 1000X stock) were suspended in DMSO and added to cultures. 2- 
aminoethoxydiphenyl borate (2-APB, 20 µM) was added to neurons 45 mins 
before NMDA. 
Sucrose Gradients 
Brain tissue from two month-old mice was washed once in 1X PBS, 
homogenized in 2 ml of 0.8 M sucrose and centrifuged at 10, 000 rpm for 10 min.  
1.5 ml of the supernatant was subsequently removed and layered on 2.0 M 
sucrose in an SW41 centrifuge tube.  2.25 of 1.3 M, 1.95 M and 2.5 M sucrose 
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 were layered on top of the brain lysates, which was followed by centrifugation at 
40K for 5 h.  An 18- gauge needle was used to pierce the bottom of the tube and 
1 ml fractions were collected; 200 l of each fraction were removed to a clean 
microcentrifuge.  2.5 volumes of 100% ethanol was added and the tubes were 
stored overnight at -20C.  The precipitates were collected by centrifugation and 
with 70% ethanol.  The pellets were suspended in 100 l of 1X SDS sample and 
analyzed by western blotting for CPEB4 (antibody dilution of 1:1000) or PDI 
(antibody dilution of 1:750, Santa Cruz). 
Immuno Electron Microscopy 
CPEB4 enriched fractions were pooled and diluted 5-fold in homogenization 
buffer (HB) (20 mM Tris-HCl, pH 7.5, 2 mM MgCl2, 50 mM KCl, 250 mM sucrose, 
1 mM phenylmethylsulfonyl fluoride).  Pooled fractions were then centrifuged for 
1h at 36K and the pellet washed once with 1X PBS.  Pellets were then incubated 
with CPEB4 antibody (1:500) for 1 h at room temperature.  Pellets were then 
washed twice with 1X PBS and blocked for 15 minutes with 5% BSA/PBS.  
Subsequently, the pellets were incubated with 10 nm goat anti-rabbit gold-
conjugated antibody (1:25, Tedpella) for 1h at room temperature.  The pellets 
were then washed three times 5 minutes each with 1X PBS and fixed with 2.5% 
glutaraldehyde in 0.1 M phosphate buffer pH 8.0.   
Measurement of intracellular Ca2+ 
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 Neurons were plated at a density of 0.5x105 cells/well in a 96 well dish and 
maintained in neurobasal medium containing B27.  DIV16 hippocampal neurons 
were loaded with 1 µM Fluo-3/AM, a  Ca2+-sensitive fluorescent probe 
(Invitrogen), containing 0.02% Pluronic F-127 (Molecular Probes) in Hank’s 
buffered salt solution for 30 minutes at 37oC.  The plates were gently washed 
with buffer and incubated for another 30 minutes at 37oC to permit de-
esterification of intracellular Fluo-3/AM.  The fluorescence of Fluo-3 is a measure 
of the Ca2+ concentration and was determined using a POLARstar Optima 
fluorescence plate reader (BMG Labtech) equipped with 485/10 nm excitation 
filter and a 520/10 nm emission filter.  After dye loading, neurons were treated 
with various reagents (see Figure 3.11 for a complete list) and the relative 
fluorescence intensity was determined. 
Measurement of ER calcium 
ER calcium measurements were carried out using the ER targeted cameleon 
construct, D1ER (Palmer et al., 2004).  Primary hippocampal neurons (DIV 12) 
were transfected with 1.6 mg of the pD1ER using Lipofectamine 2000 and 
maintained in Neurobasal medium.  Four days after transfection, the appropriate 
pharmacological agent (see Figure 3.12) was added to the neurons and 
fluorescence resonance energy transfer (FRET) from the donor fluorophore CFP 
(441/485 nm excitation/emission) to the acceptor fluorophore YFP (441/550 nm 
excitation/emission) was measured.  The magnitude of FRET signal is 
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 proportional to the amount of calcium in the ER.  Cells were imaged on Olympus 
IX 70 Inverted Light Microscope.  To calibrate the relative FRET signal, Rmin was 
obtained by treating the cells with 3 mM EGTA and 2 µM ionomycin and the 
FRET signal from untreated cells was set as Rmax. Fluorescence images were 
background corrected.  The emission ratio (FRET/CFP) was quantified before 
and after treatment of the neurons and percent calcium change was calculated 
by setting Rmin as -100% change and Rmax as 0% change.  See Figure 3.12 for 
an illustration of the FRET assay. 
Plasmid constructions 
CPEB4 internal serial deletion was done by PCR using pcDNA-mycCPEB4 as 
template and various primer sets in PCR reactions using Pfu Turbo for 
amplification. Primers used to generate different deletion mutants are: for D1, 
C4-D1-R, CCCGTAATCCCCCATATGGGAT and C4-D1-F, 
GGTCAGGAAGCTGGAATACTG, for D2, C4-D2-R, 
TGGACTTGGGGAAAGCTGCTG and C4-D2-F, 
AATAATGGTGCTCTCTTGTTTC, for D3, C4-D3-R, 
AGCTGAAGCGCCAGGGACCCCTC and C4-D3-F, 
CCTTTGAAGAAAAATTTCGC, for 8  
D4, C4-D4-R, TGAGATTGAGTTCAGGGGTG and C4-D4-F, 
GGGTCACCTCACTGCTTCAC, for D5, C4-D5-R, 
CAGACCACTATGAAGAGGTTG and C4-D5-F, 
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 ATCAAGGATAAACCAGTGCAG, for D6, C4-D6-R, 
GGTTGGACTTGATACACACAG and C4-D6-F, ATAGATAAACGGGTGGAGGT, 
for D7, C4-D7-R, CTCTCCATGCTGCAGCTGAAC and C4-D7-F, 
TAAAGGATAACTGCAGTGCTC. PCR products were passed through a DyeEx 
column (Qiagen) to remove free nucleotide before digested by DpnI to remove 
template plasmid then ligated overnight in the presence of T4 PNK 
(Polynucleotide Kinase) by T4 DNA ligase. Selected clones were verified by 
sequencing. N-EGFP (NLS-MS2-EGFP) plasmid was constructed by inserting 
BamHI-NotI (NotI site filled in by T4 DNA polymerase) fragment from pG14-MS2-
GFP into pEGFP-N3 (Clontech) digested by (EcoRI site filled in by T4 DNA 
polymerase). For minimal NES domain determination, various primers were used 
in PCR reactions to amplify different regions of CPEB4 and inserted between 
PstI and KpnI sites of pNLS-MS2-EGFP. Primers used to amplify various regions 
are: for N-EGFP-268, C4-218PstI, 
GGCCCTGCAGTCAATAATGGTGCTCTCTTG and C4-486KpnI, 
GGCCGGTACCTTCCACTCTCTCCCCATTCTG; for N-EGFP-145: C4-486KpnI, 
GGCCGGTACCTTCCACTCTCTCCCCATTCTG and C4-341PstI, 
GGCCCTGCAGTCGGTGGAATAACACCCCTGAAC; for N-EGFP-110: C4-
486KpnI, GGCCGGTACCTTCCACTCTCTCCCCATTCTG and C4-376PstN, 
GGGCCCCTGCAGGAACGCCCCAGGACGTTTG; for N-EGFP-83: C4-
424KpnC, GGGCCCGGTACCGTTTAGACGACCTTTAATGG and C4-341PstI, 
GGCCCTGCAGTCGGTGGAATAACACCCCTGAAC; for N-EGFP-48: C4-
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 424KpnC, GGGCCCGGTACCGTTTAGACGACCTTTAATGG and C4-376PstN, 
GGGCCCCTGCAGGAACGCCCCAGGACGTTTG. NESm of CPEB4 were 
generated by site directed mutagenesis using primers, L387-391AF, 9  
CGTTTGACATGCACTCAGCAGAGAGCTCAGCAATTGACATAATGAGAGC 
and L387-391AR, 
GCTCTCATTATGTCAATTGCTGAGCTCTCTGCTGAGTGCATGTCAAACG, in a 
50 µl PCR reaction contained 2.5 units PfuTurbo (Stratagene) a reaction as 
directed by user manual. PCR cycling condition for both serial internal deletion 
and site directed mutagenesis is the same as described below: 95oC for 30 sec. 
followed by 16 cycles of 95 ºC for 30 sec, 55 ºC for 1min, 68 ºC for 12 min. then 
ended in 68 ºC for 5 min 
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CHAPTER IV 
 
DISCUSSION AND CONCLUSIONS 
 
In this thesis, I have focused on the role of cytoplasmic polyadenylation in 
mitochondrial activity and neuronal function and survival. CPEB has earlier been 
shown to be involved in oocyte maturation, senescence, neuronal plasticity, 
learning and memory. This study explores novel regulatory roles of CPEB and 
CPEB4 in cellular physiology.  
The role of cytoplasmic polyadenylation binding protein CPEB in 
mitochondrial function and neuronal growth and branching was elucidated in 
chapter II. The CPEB KO mice have various defects in oocyte and sperm 
development, learning and memory defects (Richter, 2007). One additional area 
of CPEB influence is in control of senescence. Mouse embryonic fibroblasts 
(MEFs) and human foreskin fibroblasts deficient in CPEB can successfully 
bypass senescence (Burns and Richter, 2008; Groisman et al., 2006), whereas 
WT MEFs and WT human fibroblasts cannot bypass senescence and exit the cell 
cycle after passage 6. This senescence bypass is mediated by p53 in mouse and 
human cells and additionally requires myc in mouse fibroblasts (Burns and 
Richter, 2008; Groisman et al., 2006; Groppo and Richter). In addition to its role 
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in senescence, p53 has also been shown to be important for regulating 
mitochondrial function and thereby implicating CPEB in mitochondrial regulation 
(Matoba et al., 2006); in fact CPEB deficient human fibroblasts show reduced 
mitochondrial mass and function (Burns and Richter, 2008).  I have uncovered 
that CPEB KO mice also display brain-specific mitochondrial dysfunction 
phenotype. CPEB is important for cytoplasmic polyadenylation induced 
translation of a mitochondrial protein NDUFV2, which is part of the ETC complex 
I. CPEB KO mice thus have defects in ETC complex I amount and activity, and 
exhibit reduced mitochondrial oxygen consumption and ATP production without 
affecting mitochondrial amounts. This reduction in mitochondrial ATP production 
is not compensated by increased glycolysis (as happens in Warburg effect) 
leading to reduction in overall ATP levels. CPEB regulates the translation of 
NDUFV2 by binding to the CPE elements in the 3’UTR of NDUFV2. These 
results show an important role for translational control in regulating mitochondrial 
function. A consequence of this impaired mitochondrial function is the loss of 
growth and branching in CPEB KO neurons. Hippocampal neurons cultured from 
CPEB KO mouse brains show reduced dendritic branches and reduced length of 
the branches. These defects can be rescued either by ectopic expression of 
NDUFV2 or by increasing ATP levels using the high energy substrate 
phosphocreatine showing the importance of mitochondrial function in regulating 
neuronal growth.  
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In chapter III, I focused on the nucleo-cytoplasmic shuttling of cytoplasmic 
polyadenylation binding protein 4 (CPEB4) and its effects on neuronal function. 
CPEB4 is predominantly expressed in brain and is found to localize mostly to the 
cell body of neurons (Huang et al., 2006; Theis et al., 2003). A small portion of 
CPEB4 protein also localizes to synaptic regions and cofractionates with the post 
synaptic density (Huang et al., 2006). To investigate whether this localization 
changes upon stimulation, neurons were treated with N-methyl D-aspartate 
(NMDA). Surprisingly, CPEB4 localized to nucleus upon NMDA treatment. Other 
neuronal stimulators such as glutamate and 2-amino-3-(3-hydroxy-5-methyl-
isoxazol-4-yl)propanoic acid (AMPA) but not dihydroxyphenylglycine (DHPG) 
also produce the same nuclear localization of CPEB4 suggesting that stimulation 
of ionotropic glutamatergic receptors leads to nuclear localization of CPEB4. 
These neuronal stimulators cause changes in cellular ionic balance and thus 
propagate their signals; cytoplasmic calcium levels as well as ER calcium levels 
change during stimulation. I found that ER calcium depletion and not cytoplasmic 
calcium increase plays a bigger role in mediating CPEB4 nuclear localization. 
Although CPEB4 does not have a clear nuclear localization signal in its 
sequence, the nuclear export signal was identified to be between residues 341-
424. This nuclear localization probably affords protection against apoptosis 
during stress conditions such as ischemia or oxygen glucose deprivation. 
Neurons lacking CPEB4 do not survive beyond day 8 in culture highlighting the 
importance of CPEB4 in neuronal function.  
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CPEB and mitochondria function 
Mitochondria are important for cell survival and function. This is 
exemplified by the fact that mitochondrial oxidative phosphorylation defects are 
one of the most common inborn errors of metabolism (Kirby and Thorburn, 
2008). In this thesis, CPEB was shown to play a role in regulating mitochondrial 
function specifically through its effect on ETC complex I, thus highlighting the 
importance of CPEB in body homeostasis. I observed these mitochondrial 
defects in hippocampus as well as in the cortex. Additional analysis on specific 
areas of the brain need to be undertaken to see if there is any brain region 
specific dysfunctions. Hippocampal and purkinje cerebellar neurons have high 
metabolic rates and glucose utilization and they might be the most affected 
regions. I have focused on the hippocampus, but studies on purkinje neurons will 
prove useful. Purkinje neurons are also known to be highly branched and it is 
possible that the neuronal branching in this area of the brain is also affected in 
the CPEB KO brain.  
Defects in one subunit of an ETC complex have been shown to have 
damaging consequences for the cell. Hoefs et al. (2008) showed that mutation in 
an ETC complex I component NDUFA2 can cause reduced complex I function 
and lead to Leigh disease (Hoefs et al., 2008). Mutation in another complex I 
protein NDUFA1 gene has been linked to Leigh disease, myotonic epilepsy and 
developmental delay and this patient showed reduced levels of complex I 
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(Fernandez-Moreira et al., 2007). A 4 bp deletion in the NDUFV2 gene is 
associated with early-onset hypertrophic cardiomyopathy and encephalopathy. 
Patients with this mutation had a significant complex I deficiency. These studies 
indicate that mutation or defect in a single subunit of this complex can 
dramatically affect the amount and functioning of the entire complex. This could 
manifest as a disease in human body if the dysfunction is severe. Apart from 
Leigh disease and encephalopathy, mitochondrial defect is known to be 
associated with many neurodegenerative disease such as Parkinson’s, 
Alzheimer’s and Huntington’s diseases and Amyotrophic Lateral Sclerosis 
(reviewed in (Lin and Beal, 2006). 
The master energy sensor in the cell is 5’ AMP activated protein kinase, a 
serine/threonine protein kinase, which maintains the energy status at the cellular 
as well as systemic level. It is upregulated by an increase in AMP/ATP ratio in 
the cell. Once activated, it shuts down anabolic processes and upregulates 
catabolic processes in order to conserve existing energy and acquire extra 
energy. It regulates the uptake of glucose, lipogenesis, fatty acid oxidation, 
glycolysis and many other metabolic processes. AMPK also phosphorylates 
Raptor, dissociating the mTOR complex and thereby inhibiting protein synthesis. 
Thus, AMPK activation down-regulates general protein synthesis. It will be 
interesting to check the level of activation of AMPK in the CPEB KO mice brain 
as well as in the rest of the tissues. The reduced ATP levels in CPEB KO should 
activate AMPK which would then inhibit general protein synthesis. Additionally, 
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CPEB KO also has inhibition of CPEB-mediated translation control activation. 
This is intriguing and experiments on AMPK will shed more light on this 
complexity.  
 The bioenergetic defects in CPEB KO mice are due to reduced translation 
of the complex I component NDUFV2; these defects can be rescued by ectopic 
expression of NDUFV2. Although NDUFV2 rescues the complex I defect, ATP 
deficiency and the neuron growth defect, the rescue is not complete, suggesting 
that there might be other players in this pathway. One plausible alternative 
mechanism could involve other proteins in complex I itself. Complex I contains 45 
proteins of which 4 were shown to be unaffected by CPEB. Expression of the 
remaining 41 subunits was not tested in this work. There might be CPEB-
dependent expression of one or more of those complex I subunits, albeit 
indirectly because their mRNAs do not possess CPE sequences in their 3’UTRs. 
In a 2-Dimensional electrophoresis separation analysis of complex I proteins 
from WT and CPEB KO brains followed by mass spectrometry based 
identification of proteins, only NDUFV2 protein level was found to be reduced in 
CPEB KO brain (data not shown). Moreover, NDUFV2 mRNA contains CPE 
sequence in its 3’UTR. Therefore, I focused the study on NDUFV2. Another 
plausible explanation for incomplete rescue by NDUFV2 could involve ETC 
complex II. CPEB KO mice also showed a minor deficiency in ETC complex II 
activity which also impacts the overall ATP production independent of complex I. 
NDUFV2 might rescue complex I function but has no effect on complex II activity 
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and therefore even after NDUFV2 ectopic expression, ATP levels are not 
restored to WT levels. Complex II, also known as succinate dehydrogenase 
(SDH), has 4 subunits – SDHA, SDHB, SDHC and SDHD. None of these 4 
mRNAs have CPEs in their 3’ UTRs, suggesting that CPEB does not play a role 
in mediating their translation activation. CPEB is computationally predicted to 
bind to about 20% of all brain mRNAs, but we do not know what its direct targets 
are. High throughput approaches such as identification of the entire set of CPEB 
bound mRNAs will help address this question and provide more insights into the 
role of CPEB. I would predict that many nuclear encoded mitochondrial genes 
have CPEs and are probably regulated by CPEB. Once we know the entire 
repertoire of CPEB bound targets, we can better understand the role of CPEB in 
mitochondrial function.  
NDUFV2 is an important component of complex I. It is one of the 14 core 
subunits which make up the minimal structural unit required for the enzyme’s 
function. NDUFV2 is highly conserved through evolution.  Complex I assembly 
proceeds through multiple steps and NDUFV2 joins in one of the last steps of the 
assembly pathway. In the absence of NDUFV2 the whole complex I falls apart 
and is not assembled properly. This explains why loss of a single subunit 
NDUFV2 leads to reduction of complex I in CPEB KO. 
Whether the regulation of NDUFV2 mRNA happens in the cell body and/or 
dendrites remains to be investigated. CPEB has been shown to regulate 
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transport of CPE-containing RNA in neurons (Huang et al., 2003). It is likely that 
CPEB transports NDUFV2 mRNA to dendrites by binding to its CPE element and 
the regulation of the translation of NDUFV2 occurs in dendrites, since CPEB as 
well as mitochondria are known to localize to dendrites. It will be interesting to 
investigate this further as this will shed light on the localization of this process.  
This phenomenon of mitochondrial regulation by CPEB might be even 
more dramatic under conditions where the demand for energy is enormous such 
as in intense neuronal activity. Upon stimulation of neurons with stimulus such as 
NMDA, CPEB gets phosphorylated and activated and mediates translational 
enhancement of its targets (Huang et al., 2002). I envision that the above 
described phenomenon of mitochondrial regulation by CPEB becomes especially 
important during increased activity of brain; the brain requires enhanced ATP 
production upon stimulation which is supplied by increasing the mitochondrial 
activity which is produced by CPEB mediated increase in NDUFV2 translation 
and thus enhanced mitochondrial complex I production. It has been shown that 
neuronal stimulation by potassium chloride (KCl) can induce GA-binding protein, 
which is a transcription factor that binds to guanine and adenine rich sites in DNA 
and is required for expression of mitochondrial ETC complex IV proteins (Zhang 
and Wong-Riley, 2000). A CPEB-mediated increase in mitochondrial biogenesis 
could be an additional mechanism for activity-dependent increases in energy 
levels. This model can be tested by stimulating CPEB KO neurons with various 
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neurotransmitters and measuring increase in mitochondrial protein synthesis in 
WT versus CPEB KO neurons.  
Mitochondrial dysfunction is also associated with many neurodegenerative 
diseases particularly Parkinson’s and Alzheimer’s diseases. Of special 
importance to this study is Parkinson’s disease because complex I has been 
implicated in its pathogenesis. It will be interesting to study if there are any 
neurodegenerative phenotypes in the CPEB KO mice. Although the mouse is not 
an ideal model system to study these diseases at the organismal level, many of 
the molecular phenotypes observed in patients with these diseases are also 
found in mouse models. These studies need to be performed in aged mice. The 
CPEB KO mice may show some molecular degeneration phenotypes upon 
staining with markers such as tyrosine hydroxylase which stains dopaminergic 
neurons. Parkinson’s disease is caused by degeneration of dopaminergic 
neurons in the substantia nigra region of the brain.       
CPEB and neuronal growth 
Neuronal growth is regulated by various factors such as netrin, NGF, Brain 
derived neurotrophic factor (BDNF) and neurotropins. Many of these growth and 
differentiation regulators act through cAMP signaling (Murray et al., 2009). CPEB 
was shown to be involved in regulating neuronal growth in Xenopus occyte 
retinal neurons (Bestman and Cline, 2008, 2009). In this thesis, I have uncovered 
the role of CPEB in regulating dendritic growth and branching in cultured mouse 
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hippocampal neurons as well as in mouse hippocampal neurons in vivo. Thus, 
CPEB plays an important role in neuronal growth. CPEB knockout mice exhibit 
synaptic plasticity as well as learning and memory defects, possibly due to its 
effect on neuronal branching and growth (Alarcon et al., 2004; Berger-Sweeney 
et al., 2006; Tay and Richter, 2001; Zearfoss et al., 2008). CPEB KO neurons are 
less branched and probably less connected to other neurons and cells in their 
surroundings.  
 Defect in neuronal branching can be rescued by chronic treatment of 
neurons with phosphocreatine, which is a high energy substrate. Upon entering 
the cells, phosphocreatine donates its high energy phosphate to ADP to form 
ATP thus increasing the ATP levels in a reaction catalyzed by creatine kinase. 
We surmise this is the mechanism by which phosphocreatine rescues neuronal 
branching defect. But it is possible that there are other mechanisms at play. For 
instance, creatine is known to activate signaling pathways like Akt/PKB leading to 
cellular modifications and signaling which might lead to the observed changes in 
dendrite growth and morphogenesis (Ceddia and Sweeney, 2004; Deldicque et 
al., 2007). 
Significance of CPEB4 
Many proteins such as transport receptors and adaptors, steroid hormone 
receptors, transcription factors, cell cycle regulators and RNA-binding proteins 
are known to shuttle between the nucleus and cytoplasm. Heterogeneous 
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nuclear ribonucleoproteins (hnRNPs) were the first RNA binding proteins to be 
discovered to shuttle between nucleus and cytoplasm (Dreyfuss et al., 1993). 
Initially RNA-binding proteins were thought to just transport mRNA into 
cytoplasm, but many studies have shown that these proteins also control the 
activities of the bound mRNAs in the cytoplasm (Shyu and Wilkinson, 2000). 
Many RNA-binding proteins such as hnRNPA1, hnRNP K, Sex lethal (SXL), 
bicoid and HuD are known to shuttle between cytoplasm and nucleus (Gama-
Carvalho and Carmo-Fonseca, 2001). CPEB was previously shown to shuttle 
between the nucleus and cytoplasm and was shown to regulate alternate splicing 
of collagen 9a1 mRNA (Lin et al., 2010). CPEB4 now also joins this list of 
shuttling proteins as detailed in this thesis. It accumulates in the nucleus upon 
NMDA excitotoxicity and affords protection from apoptosis but the exact 
mechanism of how it protects the neurons is not clear. It has been demonstrated 
that the extra synaptic NMDA NR2B receptors play a major role in mediating 
excitotoxicity. Perturbing synaptic localization of NR2A NMDARs did not have an 
effect on the toxicity by exogenous NMDA suggesting the importance of extra 
synaptic receptors (Sattler et al., 2000). These extra synaptic receptors are 
present in the cell body of the neurons and are thought to form clusters, through 
their interaction with PSD-95 proteins. The extra synaptic receptors are activated 
by bath glutamate exposure or ischemia and they shut off the CREB pathway, 
which in turn causes loss of mitochondrial membrane potential and cell death by 
inducing apoptosis (Hardingham et al., 2002). Perhaps CPEB4 interferes in this 
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pathway and thus prevents apoptosis? To demonstrate whether the synaptic 
NR2A receptors or the extra synaptic NR2B receptors play the major role, 
inhibitors such as ifenprodil (which specifically inhibits NR2B) can be utilized. 
Further studies need to also focus on the neuroprotective role of CPEB4.  Does 
CPEB4 also afford such protection to other cells apart from neurons? What other 
conditions will result in nuclear accumulation of CPEB4? These are some 
unresolved questions and will need to be addressed in future studies.   
CaM kinase II has been shown here to play a role in the nuclear 
localization of CPEB4 through the use of CaMKII inhibitory peptide AIPII (Ishida 
et al., 1995). CaM kinases are serine/threonine protein kinases that are regulated 
by calcium and calmodulin. CaMKII is capable of phophorylating substrates such 
as AMPA receptors, synapsin I, tyrosine hydroxylase, L-type Ca2+ channels, and 
MAP-2 (microtubule associated protein 2) (Colbran and Brown, 2004). CaMKII is 
the major PSD protein whose amounts in PSD double upon activation. The level 
of CaMKII in the PSD affects LTP and hippocampal dependent learning. The 
NMDA receptor contributes to this synaptic localization of CaMKII by binding to it. 
Targeting to NMDA receptors is responsible for the calcium linked translocation 
of CamKII to synapses (Schulman, 2004). In our results, we found that CaM 
kinase inhibition leads to loss of CPEB4 nuclear localization upon NMDA 
application.    
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In a high throughput whole genome approach, Ortiz-Zapater et al. 
identified the set of RNAs bound by CPEB4 using RNA-immunoprecipitation 
followed by microarray (Ortiz-Zapater et al., 2012). Knowing the mRNAs bound 
by CPEB4 will give us some insight into its function. One of the significant 
categories of mRNAs identified in that study is cellular functions relevant to 
apoptosis and cell death; these mRNAs could be involved in mediating CPEB4 
afforded neuroprotection against apoptosis. A large majority of the bound 
mRNAs are related to general translation factors and ribosomal proteins, thus 
suggesting a role for CPEB4 in translation control of all mRNAs. Interestingly, 
there are many calcium regulatory genes such as commd5 (copper metabolism 
domain containing gene 5), tpm1 (tropomyosin 1) in the list of mRNAs bound by 
CPEB4. Commd5 protein expression is negatively regulated by extracellular 
calcium concentration and Tpm1 is involved in calcium dependent regulation of 
muscle contraction. Exploring the functions of these mRNAs will provide useful 
hints for elucidating CPEB4 function.   
 
 
Importance of CPEB family proteins 
In this thesis and as detailed in the literature, the importance of CPEB family 
proteins is being recognized for their critical role in cellular function. The founding 
member CPEB was originally discovered in Xenopus, but now CPEB family 
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proteins have been demonstrated to be present in many organisms and play 
important roles in cell physiology. These proteins perform their functions by 
regulating mRNA translation, which go on to fine tune various processes in the 
cell. It will be really beneficial to identify the entire repertoire of mRNA bound by 
these RNA binding proteins. High throughput analysis such as Hits-CLIP (High 
throughput sequencing of tags obtained upon cross linking and 
immunoprecipitation) can be performed in order to understand the function of 
these proteins and their interacting mRNAs. Hits-CLIP involves cross linking the 
protein to their interacting mRNAs and immunoprecipitation of the cross linked 
complexes followed by sequencing of these mRNAs tags obtained (Licatalosi et 
al., 2008). Knowledge of the mRNAs bound to CPEB1-4 can help us better 
understand their role in cellular functions.  
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Conclusions 
CPEB plays an important role in oogenesis, cell division, senescence, 
neuronal synaptic plasticity, learning and memory. Such pleiotropism places 
CPEB in an important stature in the cell. Recently, CPEB has been shown to be 
related to three similar proteins (CPEB2-4), which together constitute the CPEB 
family. This thesis describes research into role of CPEB in mitochondrial function, 
its implications in neuronal growth and branching 173and explores the causes 
and consequences of nucleo-cytoplasmic shuttling of CPEB4. These two proteins 
are also important for neuronal growth, function and survival. Thus, CPEB family 
proteins are vital regulators of cellular physiology.     
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